Codeine

RX_CODEINE

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — N02AJ0[6-9]\|N02AA59\|N02AA79 1 out of 7 registries used, show all original rules.	85859
4. Check minimum number of events Min. number of events 3	85859
5. Include endpoints None	85859
6. Filter based on genotype QC (FinnGen only)	85859

Control definitions (FinnGen only)

Control exclude: RX_OPIOIDS

Extra metadata

First used in FinnGen datafreeze: DF10

NAME	RX_CODEINE
CONTROL_EXCLUDE	RX_OPIOIDS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	N02AJ0[6-9]\|N02AA59\|N02AA79
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Codeine based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	85859	49702	36157
Unadjusted period prevalence (%)	16.52	16.94	15.94
Median age at first event (years)	54.53	52.68	57.08

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
13651: Matched controls
98910

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R06.0

ICD-10 Finland

Dyspnoea

2.7

323.0

2753

8364

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.8

323.0

3033

9019

A02BC05

ATC

esomeprazole; systemic

2.8

323.0

4389

14472

M01AE02

ATC

naproxen; oral, rectal

2.6

323.0

8182

35700

J01AA02

ATC

doxycycline; systemic

2.9

323.0

9419

43264

H02AB06

ATC

prednisolone; systemic

2.9

323.0

6106

21487

M01AE03

ATC

ketoprofen; systemic, rectal

2.8

323.0

4078

13109

N06AX11

ATC

mirtazapine; oral

3.7

323.0

5070

13533

M01AC06

ATC

meloxicam; systemic, rectal

3.0

323.0

3576

10314

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.3

323.0

4559

13030

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

7.6

323.0

2060

2270

M03BX02

ATC

tizanidine; oral

4.5

323.0

9364

32110

M54.4

ICD-10 Finland

Lumbago with sciatica

6.2

323.0

2843

4023

WX404

NOMESCO Finland

Intravenous generell anesthesy

3.2

323.0

2577

6741

M25.5

ICD-10 Finland

Pain in joint

3.3

323.0

3988

11130

N06AX21

ATC

duloxetine; oral

6.1

323.0

1909

2567

AA1AD

NOMESCO Finland

CT of head and brain

3.4

323.0

2394

5754

M54.5

ICD-10 Finland

Low back pain

4.2

323.0

5921

15397

M54.9

ICD-10 Finland

Dorsalgia, unspecified

4.1

323.0

1985

3909

S18

ICPC

Laceration/cut

2.5

323.0

4361

15515

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.5

323.0

4149

14771

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.2

323.0

7224

33530

M01AH05

ATC

etoricoxib; oral

4.5

323.0

8149

24511

X58

ICD-10 Finland

Exposure to other specified factors

3.2

323.0

2479

6342

A02BC02

ATC

pantoprazole; systemic

3.9

323.0

8429

28772

L03

ICPC

Low back symptom/complaint

3.1

323.0

3801

11080

ZXA00

NOMESCO Finland

Right side

3.0

323.0

2506

6892

WX408

NOMESCO Finland

General anesthesy, balanced

3.3

323.0

3416

9183

N05CF02

ATC

zolpidem; oral

3.8

323.0

2563

5621

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.6

323.0

5871

21986

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.0

323.0

8022

40738

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

8.0

323.0

1584

1589

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

7.7

323.0

1079

1094

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

7.8

323.0

918

908

R4110

NOMESCO Finland

Physiotherapy

3.3

323.0

3086

8015

N02AA05

ATC

oxycodone; systemic

13.1

323.0

1540

948

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

31.1

323.0

11771

16581

N02AX02

ATC

tramadol; systemic, rectal

9.6

323.0

6577

8715

C07AB07

ATC

bisoprolol; oral

2.6

323.0

3689

12356

N03AX12

ATC

gabapentin; oral

11.7

323.0

2656

1999

X59

ICD-10 Finland

Exposure to unspecified factor

3.5

323.0

3172

7852

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

28.2

323.0

1656

481

N03AX16

ATC

pregabalin; oral

11.3

323.0

4038

3554

WX002

NOMESCO Finland

Sedation and analgesia

3.5

323.0

2025

4646

R03AC02

ATC

salbutamol; inhalant

2.5

323.0

7559

32832

J01FF01

ATC

clindamycin; systemic

2.6

323.0

3500

11403

J01DB01

ATC

cefalexin; oral

3.6

323.0

11691

61528

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.9

323.0

3851

11789

N05BA04

ATC

oxazepam; oral

3.2

323.0

4083

11513

M75.1

ICD-10 Finland

Rotator cuff syndrome

4.0

323.0

1982

4013

M01AB05

ATC

diclofenac; systemic, rectal

3.9

323.0

9275

34671

B01AB05

ATC

enoxaparin; parenteral

3.2

323.0

2872

7709

M01AE01

ATC

ibuprofen; systemic, rectal

3.6

323.0

12449

73520

N02BE01

ATC

paracetamol; systemic, rectal

7.8

323.0

12436

56124

M03BC01

ATC

orphenadrine (citrate); systemic

4.5

323.0

4353

9335

M01AH01

ATC

celecoxib; oral (coxibs)

3.9

323.0

1533

3081

EB1AA

NOMESCO Finland

Tooth X-ray examination

2.1

323.0

7195

34049

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.8

323.0

3135

9509

N05AH04

ATC

quetiapine; oral

3.3

323.0

3561

9676

M03BC51

ATC

orphenadrine, combinations; systemic

3.3

323.0

3987

10987

WX110

NOMESCO Finland

Local anesthesy

2.3

323.0

9760

51781

M79.6

ICD-10 Finland

Pain in limb

3.4

323.0

4926

14056

P01AB01

ATC

metronidazole; oral, rectal

2.5

323.0

5087

18998

N05CF01

ATC

zopiclone; oral

3.3

323.0

3944

10926

N06AX16

ATC

venlafaxine; oral

3.5

323.0

2576

6179

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

2.2

323.0

6830

31359

R51.80

ICD-10 Finland

Headache

3.5

323.0

3127

7806

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.9

323.0

2846

8287

N02AJ06

ATC

codeine and paracetamol; systemic

21.0

323.0

10290

12599

A03FA01

ATC

metoclopramide; systemic, rectal

3.0

318.0

2242

6125

J01MA02

ATC

ciprofloxacin; systemic

2.2

317.1

4218

16425

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.3

316.3

3716

13621

ZXA05

NOMESCO Finland

Left side

2.9

311.0

2316

6549

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.3

308.2

1813

4345

A02BC03

ATC

lansoprazole; oral

2.6

307.4

2699

8439

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.8

304.4

2436

7200

C07AA05

ATC

propranolol; systemic

2.5

302.3

2942

9739

M02AA07

ATC

piroxicam; topical

2.4

296.7

3130

10802

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

10.5

295.9

644

462

L86

ICPC

Back syndrome with radiating pain

7.0

294.8

819

891

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

4.1

293.9

1318

2508

TPH04

NOMESCO Finland

Cathetrisation of vein

2.8

293.4

2342

6895

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

4.9

292.0

1089

1720

R01AD09

ATC

mometasone; nasal

2.0

289.4

6087

28503

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.8

288.9

2283

6674

N06AB10

ATC

escitalopram; oral

2.3

288.4

3633

13669

M54

ICD-10 Finland

Dorsalgia

3.1

286.0

1892

4917

SAA01

NOMESCO Finland

Simple examination of mouth

2.0

284.3

9721

54594

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.1

281.4

4591

19340

L28

ICPC

Limited function/disability (L)

3.6

280.3

1497

3311

G44.2

ICD-10 Finland

Tension-type headache

2.9

279.5

2088

5880

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.2

276.6

1695

4165

A02BC01

ATC

omeprazole; systemic

2.4

276.4

3098

10972

G43.9

ICD-10 Finland

Migraine, unspecified

3.5

272.3

1478

3307

L08

ICPC

Shoulder symptom/complaint

3.1

272.0

1725

4342

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

269.7

3080

10988

R07.4

ICD-10 Finland

Chest pain, unspecified

2.7

268.7

2283

6942

C09CA06

ATC

candesartan; oral

3.0

268.2

1819

4795

N06AA09

ATC

amitriptyline; systemic

5.8

264.7

845

1108

N05BA01

ATC

diazepam; systemic, rectal

3.2

264.2

1598

3882

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.5

262.5

2515

8176

F51.0

ICD-10 Finland

Nonorganic insomnia

2.6

256.9

2298

7180

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.7

254.8

2147

6478

SPAT1153

SPAT

Removal of sutures

2.3

252.5

2915

10409

UJF32

NOMESCO Finland

Coloscopy

2.7

250.6

2116

6385

WX402

NOMESCO Finland

General anaesthesia

2.7

244.9

1959

5717

I10

ICD-10 Finland

Essential (primary) hypertension

2.2

238.8

3058

11425

J01FA10

ATC

azithromycin; systemic

1.8

236.1

7950

42789

J01CA04

ATC

amoxicillin; systemic

2.1

235.8

11403

69918

L17

ICPC

Foot/toe symptom/complaint

2.3

234.7

2624

9180

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.9

233.6

1691

4625

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.1

230.6

1484

3748

N06AB04

ATC

citalopram; systemic

2.3

229.6

2643

9367

M48.0

ICD-10 Finland

Spinal stenosis

6.6

227.2

660

761

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

10.2

225.0

496

363

Z01.8

ICD-10 Finland

Other specified special examinations

2.4

224.7

2384

8104

R03AK07

ATC

formoterol and budesonide; inhalant

2.4

223.7

2354

7968

R01AD12

ATC

fluticasone furoate; nasal

1.9

223.6

4423

19671

M79.1

ICD-10 Finland

Myalgia

2.7

222.6

1861

5551

M17.1

ICD-10 Finland

Other primary gonarthrosis

4.7

221.9

851

1374

A01

ICPC

Pain general/multiple sites

4.0

220.9

1005

1920

J01FA06

ATC

roxithromycin; oral

1.9

218.7

4500

20265

J45.9

ICD-10 Finland

Asthma, unspecified

2.5

218.0

2042

6492

S06.0

ICD-10 Finland

Concussion

2.8

217.8

1693

4830

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

216.5

5460

26380

J01FA09

ATC

clarithromycin; systemic

2.0

214.8

3655

15297

R42

ICD-10 Finland

Dizziness and giddiness

2.4

214.7

2170

7176

WX320

NOMESCO Finland

Spinalanesthesy

2.3

214.5

2311

7897

WX290

NOMESCO Finland

Other blockade of nerve

1.8

214.0

7120

37610

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.3

213.8

1229

2849

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

3.1

213.5

1391

3533

L15

ICPC

Knee symptom/complaint

2.5

213.1

1954

6131

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

5.8

211.8

676

882

J01MA12

ATC

levofloxacin; systemic

2.6

210.6

1785

5355

M54.3

ICD-10 Finland

Sciatica

6.0

210.6

652

818

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

9.9

208.5

466

350

M01AG02

ATC

tolfenamic acid; oral, rectal

2.6

207.3

1854

5731

N06CA01

ATC

amitriptyline and psycholeptics; systemic

4.1

205.2

914

1709

G56.0

ICD-10 Finland

Carpal tunnel syndrome

3.3

203.8

1202

2838

N03AX09

ATC

lamotrigine; oral

3.5

203.3

1087

2379

SPAT1254

SPAT

Administration of medicine

2.4

200.1

1954

6327

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.1

197.1

1244

3082

A06AC01

ATC

ispaghula (psylla seeds); oral

2.3

196.2

2090

7071

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.9

195.9

3799

16593

M54.2

ICD-10 Finland

Cervicalgia

3.8

195.0

942

1892

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

2.0

194.8

3211

13181

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.6

193.9

1019

2197

ZXA10

NOMESCO Finland

Bilateral

2.5

191.8

1828

5830

J01CE02

ATC

phenoxymethylpenicillin; oral

1.8

191.3

9985

59639

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.1

191.1

1197

2947

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

3.3

190.6

1097

2538

R52.2

ICD-10 Finland

Other chronic pain

8.1

190.2

479

444

R53

ICD-10 Finland

Malaise and fatigue

2.1

190.1

2860

11299

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.7

190.1

946

1948

R06AE07

ATC

cetirizine; oral

1.7

189.9

5933

30288

J02AC01

ATC

fluconazole; systemic

1.8

189.5

4747

22594

M01AX17

ATC

nimesulide; oral

2.7

188.1

1510

4366

J01DA01

ATC

[U] cefalexin; systemic

1.7

187.7

7704

42619

SGA01

NOMESCO Finland

Tooth opening as first aid

2.2

187.7

2439

9042

N06AB06

ATC

sertraline; oral

2.4

187.6

1812

5817

R03DC03

ATC

montelukast; oral

2.4

185.4

1947

6522

L01

ICPC

Neck symptom/complaint

2.4

184.3

1797

5793

K02.1

ICD-10 Finland

Caries of dentine

1.7

182.1

8066

45430

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

6.0

181.7

565

711

M79.7

ICD-10 Finland

Fibromyalgia

6.8

181.5

513

567

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.2

181.4

2154

7651

K04.5

ICD-10 Finland

Chronic apical periodontitis

2.2

181.3

2309

8469

SPAT1263

SPAT

Sampling

1.7

181.2

5742

29295

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

2.0

181.0

2818

11257

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.5

180.5

976

2149

C03CA01

ATC

furosemide; systemic

2.2

180.2

2202

7925

N06AX12

ATC

bupropion; oral

2.8

180.1

1350

3739

R50.9

ICD-10 Finland

Fever, unspecified

2.3

180.0

1915

6449

C08CA01

ATC

amlodipine; oral

2.4

179.6

1757

5666

M70.6

ICD-10 Finland

Trochanteric bursitis

4.6

179.1

700

1148

N05BA12

ATC

alprazolam; oral

3.1

178.1

1134

2817

R02

ICPC

Shortness of breath/dyspnoea

2.7

177.5

1396

3979

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

3.2

177.0

1057

2509

A28

ICPC

Limited function/disability NOS

3.0

176.8

1157

2929

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.8

175.0

1270

3444

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.8

172.8

3770

17013

R52.9

ICD-10 Finland

Pain, unspecified

3.2

172.3

1019

2399

G47.3

ICD-10 Finland

Sleep apnoea

2.6

171.8

1475

4423

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.4

171.8

1664

5331

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.6

171.2

881

1861

K04.0

ICD-10 Finland

Pulpitis

2.4

171.1

1785

5941

L13

ICPC

Hip symptom/complaint

3.2

169.1

1004

2370

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.4

168.0

1670

5419

SPAT1301

SPAT

No procedures

1.8

166.9

3819

17469

R60.0

ICD-10 Finland

Localized oedema

3.4

166.6

929

2089

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.8

165.7

3891

17940

R05

ICPC

Cough

2.0

165.5

2738

11150

M02AA10

ATC

ketoprofen; topical

2.7

165.0

1335

3864

M54.6

ICD-10 Finland

Pain in thoracic spine

3.2

164.2

970

2280

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.4

163.2

892

1976

L12

ICPC

Hand/finger symptom/complaint

2.3

162.8

1717

5735

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.9

162.5

765

1497

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.6

161.3

1394

4186

R01AD08

ATC

fluticasone; nasal

1.8

161.0

3606

16338

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.2

160.8

2052

7493

EBA05

NOMESCO Finland

Complicated extraction of tooth

2.1

160.8

2176

8154

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.6

160.7

7200

40008

Z71.8

ICD-10 Finland

Other specified counselling

1.8

160.6

3464

15493

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

9.4

159.7

367

290

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.8

159.1

763

1517

L02

ICPC

Back symptom/complaint

2.6

158.7

1384

4176

N03AE01

ATC

clonazepam; systemic

4.3

158.2

665

1171

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

157.8

2533

10168

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

156.4

1955

7066

A98

ICPC

Health maint/preventive medicine

2.2

155.9

12568

83006

J20

ICD-10 Finland

Acute bronchitis

2.9

155.1

1109

2968

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.8

154.4

3920

18442

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.8

153.8

1123

3045

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

6.6

153.6

440

495

M01AX05

ATC

glucosamine; oral

3.7

151.9

747

1516

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

4.1

151.2

665

1222

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.1

150.0

940

2301

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

4.9

149.9

553

851

R01BA52

ATC

pseudoephedrine, combinations; oral

2.0

149.0

2446

9877

M54.1

ICD-10 Finland

Radiculopathy

7.1

149.0

408

430

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

5.3

147.8

503

706

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.9

146.9

1006

2615

W19

ICD-10 Finland

Unspecified fall

2.7

146.5

1163

3315

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.5

146.4

782

1698

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

16.6

145.7

259

115

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.1

145.6

1921

7090

R74

ICPC

Upper respiratory infection acute

1.7

145.6

4995

25564

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

12.9

145.0

285

163

N06AX26

ATC

vortioxetine; oral

2.8

145.0

1097

3038

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.1

145.0

1958

7297

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.6

144.7

1196

3491

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.7

143.4

1117

3148

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

143.0

1484

4895

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

8.7

142.4

341

290

N07BA03

ATC

varenicline; oral

3.6

142.0

726

1521

R06AX27

ATC

desloratadine; oral

1.7

141.9

3801

18080

NF1AA

NOMESCO Finland

Hip X-ray examination

4.8

141.6

531

831

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

3.1

141.6

889

2177

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

141.5

6845

38250

UKC02

NOMESCO Finland

Cystoscopy

2.5

141.0

1296

4012

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

15.2

140.5

258

125

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.4

140.4

1358

4319

N02AJ13

ATC

tramadol and paracetamol; systemic

22.9

139.8

224

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.1

139.2

1895

7077

SPAT1283

SPAT

Restricted health certificate

1.7

138.8

3986

19328

S83.2

ICD-10 Finland

Tear of meniscus, current

3.3

138.6

790

1802

K10.3

ICD-10 Finland

Alveolitis of jaws

3.1

138.5

855

2067

R03BA05

ATC

fluticasone; inhalant

2.0

138.2

2243

8990

M16.1

ICD-10 Finland

Other primary coxarthrosis

4.8

138.1

520

817

ACC51

NOMESCO Finland

Release of median nerve

4.1

136.5

601

1104

NA1AD

NOMESCO Finland

Cervical spine CT examination

4.4

136.4

553

938

E66.01

ICD-10 Finland

Obesity due to excess calories

2.6

136.3

1162

3446

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

4.1

135.9

595

1087

D11

ICPC

Diarrhoea

2.0

135.8

2003

7725

N01

ICPC

Headache

2.0

135.0

1983

7635

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.9

134.9

926

2406

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.4

134.7

1309

4170

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.5

134.4

715

1545

SPAT1216

SPAT

Assessment of functional ability

2.5

134.0

1215

3729

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

4.8

133.9

497

769

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

3.4

133.7

730

1610

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

3.7

133.1

657

1335

NE1AA

NOMESCO Finland

Pelvis X-ray examination

4.8

133.0

491

755

S22.3

ICD-10 Finland

Fracture of rib

3.8

132.7

639

1271

N03AX11

ATC

topiramate; oral

4.7

132.4

503

798

H02AB04

ATC

methylprednisolone; systemic

2.4

132.0

1326

4294

SPAT1229

SPAT

Assessment of need for aid

3.8

131.2

619

1210

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.9

130.9

923

2439

G04CA02

ATC

tamsulosin; oral

2.1

130.9

1689

6152

N02CC04

ATC

rizatriptan; oral

2.9

130.8

915

2406

TQW40

NOMESCO Finland

Remowal of suture of skin

3.6

130.4

657

1358

M19.0

ICD-10 Finland

Primary arthrosis of other joints

5.7

130.1

415

538

SPAT1255

SPAT

Intravenous administration of medicine

3.6

130.1

673

1422

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

5.1

129.8

459

673

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

3.5

129.6

678

1445

J01MA14

ATC

moxifloxacin; systemic

3.0

129.5

844

2117

SPAT1260

SPAT

Consultation of another employee

2.0

129.3

2030

8010

C10AA01

ATC

simvastatin; oral

2.0

128.9

1879

7200

T90

ICPC

Diabetes non-insulin dependent

2.6

127.9

1079

3177

A46

ICD-10 Finland

Erysipelas

2.6

127.9

1053

3059

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.2

127.2

543

968

JAH01

NOMESCO Finland

Laparoscopy

3.8

126.8

606

1197

SGC00

NOMESCO Finland

Local medication of root channels of tooth

2.2

126.4

1495

5230

R11

ICD-10 Finland

Nausea and vomiting

2.4

125.9

1178

3671

A03

ICPC

Fever

1.8

125.9

2850

12779

EMB10

NOMESCO Finland

Tonsillectomy

2.2

124.6

1503

5305

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.7

124.5

960

2681

N03AG01

ATC

valproic acid; systemic, rectal

2.8

124.5

895

2394

N02CC07

ATC

frovatriptan; oral

3.0

124.1

816

2057

S80.0

ICD-10 Finland

Contusion of knee

2.8

123.6

927

2544

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.8

123.4

920

2517

C10AA05

ATC

atorvastatin; oral

2.2

123.1

1492

5273

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.9

122.8

839

2170

R4120

NOMESCO Finland

Occupational therapy

3.4

122.4

662

1448

G43

ICD-10 Finland

Migraine

2.5

122.2

1076

3244

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.6

121.3

1036

3069

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.2

121.0

1423

4959

KMAK

NOMESCO Finland

1.5

121.0

7267

42087

H02AB07

ATC

prednisone; oral

2.3

120.9

1322

4453

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

5.7

120.9

389

510

A02BA02

ATC

ranitidine; systemic

2.2

120.6

1438

5045

E66.8

ICD-10 Finland

Other obesity

3.3

120.0

674

1518

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

119.6

1561

5696

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.8

119.5

887

2418

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.2

119.2

1443

5094

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.1

119.2

752

1842

N06AA10

ATC

nortriptyline; systemic

10.0

119.1

264

195

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

118.7

4021

20213

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

3.3

117.8

680

1562

N06AB03

ATC

fluoxetine; oral

2.2

117.4

1312

4462

R51

ICD-10 Finland

Headache

2.7

117.3

895

2481

XKD00

NOMESCO Finland

Uroflowmetry

2.5

117.1

1082

3344

M01AH02

ATC

rofecoxib; oral

3.1

116.7

743

1830

M77.1

ICD-10 Finland

Lateral epicondylitis

2.9

116.6

784

2005

R05

ICD-10 Finland

Cough

2.0

116.6

1781

6929

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

5.2

116.5

401

570

A04AA01

ATC

ondansetron; systemic, rectal

3.9

116.0

534

1020

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

2.1

115.6

1473

5316

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

7.7

115.4

296

282

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

3.0

115.3

772

1969

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.5

115.0

1034

3148

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.5

115.0

609

1309

N04BC05

ATC

pramipexole; oral

4.0

115.0

510

942

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.5

114.3

591

1246

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.8

113.9

843

2292

A06AD11

ATC

lactulose; oral

2.3

113.9

1256

4241

N06AX05

ATC

trazodone; oral

5.0

113.4

404

597

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.4

113.2

1107

3523

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.7

112.8

545

1086

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

3.0

112.5

742

1872

N02CC03

ATC

zolmitriptan; nasal, oral

2.8

112.2

808

2159

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

2.4

111.9

1051

3273

JN4BD

NOMESCO Finland

Extensive body CT

3.3

111.7

622

1390

C09AA05

ATC

ramipril; oral

2.2

111.6

1324

4625

L84

ICPC

Back syndrome without radiat pain

3.5

111.2

574

1208

D10

ICPC

Vomiting

2.1

111.2

1408

5063

B01AA03

ATC

warfarin; systemic

2.1

111.1

1507

5580

J05AB01

ATC

aciclovir; systemic

1.8

110.6

2261

9752

XF400

NOMESCO Finland

ECG with 12 standard connections

2.2

110.5

1338

4715

SPAT1097

SPAT

Recording of ECG

2.5

110.0

986

2995

J35.0

ICD-10 Finland

Chronic tonsillitis

2.2

109.4

1284

4460

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.9

109.2

737

1888

A07EC01

ATC

sulfasalazine; oral, rectal

2.7

109.2

862

2436

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

9.0

109.1

256

210

R03BA02

ATC

budesonide; inhalant

1.9

109.0

2000

8313

J45

ICD-10 Finland

Asthma

2.4

108.9

1069

3405

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

108.9

2987

14102

D07AC01

ATC

betamethasone; topical

1.6

108.6

3288

15957

N07BB01

ATC

disulfiram; oral

3.6

108.5

558

1171

JN3AD

NOMESCO Finland

Abdominal CT examination

3.3

108.0

613

1389

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.6

108.0

870

2487

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.2

108.0

628

1450

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

5.8

107.6

337

427

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

5.3

107.2

363

506

EBA00

NOMESCO Finland

Extraction of tooth

1.6

106.9

4306

22479

C09CA01

ATC

losartan; oral

2.4

106.9

1058

3383

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.5

106.7

937

2812

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.0

106.6

1539

5839

P06

ICPC

Sleep disturbance

2.2

106.5

1297

4579

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

4.6

106.2

407

651

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

3.1

106.0

646

1543

D01

ICPC

Abdominal pain/cramps general

2.0

105.7

1586

6110

B02AA02

ATC

tranexamic acid; systemic

2.1

105.4

1365

4949

A10BA02

ATC

metformin; oral

1.9

105.2

1711

6797

S83.5

ICD-10 Finland

Sprain and strain involving (anterior)(posterior) cruciate ligament of knee

2.9

104.5

714

1843

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

4.9

104.5

378

568

N89

ICPC

Migraine

2.7

104.5

817

2294

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

104.3

1563

6016

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.9

104.1

727

1903

ZX120

NOMESCO Finland

Intravenous

2.6

103.7

838

2398

SPAT1104

SPAT

Monitoring of emergency patient

3.1

103.6

647

1571

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

3.3

103.4

576

1287

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.1

102.5

634

1528

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.4

102.4

990

3125

N30.0

ICD-10 Finland

Acute cystitis

2.0

101.9

1618

6365

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.1

101.7

1366

5026

M23.8

ICD-10 Finland

Other internal derangements of knee

3.5

101.6

524

1102

P76

ICPC

Depressive disorder

2.2

101.3

1166

4007

L16

ICPC

Ankle symptom/complaint

2.2

101.3

1125

3804

SPAT1262

SPAT

Handing over of treatment supplies

2.1

101.1

1398

5207

SPAT1211

SPAT

Application of soft bandage

2.4

101.0

951

2961

R20.2

ICD-10 Finland

Paraesthesia of skin

2.6

100.9

857

2523

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.9

100.8

1763

7184

G43.3

ICD-10 Finland

Complicated migraine

4.8

100.8

374

578

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

2.2

100.7

1201

4194

WZC30

NOMESCO Finland

Teaching

2.5

99.2

892

2709

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

99.1

5090

27975

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.8

99.0

706

1873

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.8

98.0

699

1854

XX3DW

NOMESCO Finland

Time consuming IT work

3.1

97.6

599

1437

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.0

97.5

1404

5308

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

5.5

97.5

318

424

M54.8

ICD-10 Finland

Other dorsalgia

3.4

97.3

529

1160

N02CC05

ATC

almotriptan; oral

2.8

97.2

691

1828

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

3.7

97.1

467

926

ND1AA

NOMESCO Finland

Wrist X-ray examination

3.3

96.5

550

1249

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.9

96.4

660

1705

G54.0

ICD-10 Finland

Brachial plexus disorders

4.5

96.2

378

620

UJF30

NOMESCO Finland

Ileoscopy through colon

2.4

96.2

887

2729

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.8

96.0

684

1812

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

94.9

4107

21658

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

2.2

94.8

1069

3634

G56.2

ICD-10 Finland

Lesion of ulnar nerve

4.7

94.8

359

567

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

94.7

1250

4558

L11

ICPC

Wrist symptom/complaint

2.3

94.7

1028

3433

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.5

94.6

810

2393

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.3

94.5

1025

3421

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.3

94.4

1020

3399

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

3.3

94.4

525

1171

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

94.3

1833

7737

N80.9

ICD-10 Finland

Endometriosis, unspecified

3.5

94.1

484

1015

N02CC06

ATC

eletriptan; oral

3.0

94.0

596

1460

-1

NOMESCO Finland

1.5

93.9

4637

25176

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

7.1

93.8

253

261

K04.08

ICD-10 Finland

Other specified pulpit

2.2

93.4

1095

3789

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

5.1

93.4

327

474

SPAT1310

SPAT

Counselling related to known health issue

1.6

93.3

3719

19220

M01AB08

ATC

etodolac; oral

3.4

92.7

512

1134

TPH07

NOMESCO Finland

Cathetrisation of artery

2.9

92.5

640

1663

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.2

92.2

394

702

E0000UV

ATC

1.5

92.1

4682

25553

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

3.2

91.9

534

1231

K08.80

ICD-10 Finland

Toothache NOS

2.2

91.8

1064

3663

S97

ICPC

Chronic ulcer skin

4.2

91.8

391

695

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

3.5

91.2

483

1037

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.5

91.0

781

2308

R55

ICD-10 Finland

Syncope and collapse

2.2

90.9

1026

3487

C10AA07

ATC

rosuvastatin; oral

2.5

90.4

786

2339

SFA40

NOMESCO Finland

Replacement of krone of tooth

2.0

90.3

1252

4654

J01FA15

ATC

telithromycin; oral

2.4

90.0

895

2861

D06

ICPC

Abdominal pain localized other

2.2

89.5

1086

3814

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

3.4

89.4

481

1045

M89.0

ICD-10 Finland

Algoneurodystrophy

14.4

89.4

167

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

10.5

89.3

192

134

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

10.0

89.1

197

145

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

9.4

88.8

202

157

WX892

NOMESCO Finland

Monitored bed care

2.8

88.6

642

1718

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

88.3

2065

9227

N05AA02

ATC

levomepromazine; systemic

3.4

88.3

480

1052

OAA65

SPAT

1.9

88.0

1619

6692

H01

ICPC

Ear pain/earache

1.9

87.8

1544

6281

R03AC03

ATC

terbutaline; inhalant

1.9

87.6

1605

6625

M13.9

ICD-10 Finland

Arthritis, unspecified

2.7

87.3

687

1931

R03BB04

ATC

tiotropium bromide; inhalant

2.5

87.2

758

2256

M47.82

ICD-10 Finland

Other spondylosis, cervical region

8.3

87.2

213

188

K04.1

ICD-10 Finland

Necrosis of pulp

2.0

86.3

1194

4433

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

2.0

85.9

1292

4957

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.2

85.5

509

1193

A02BC04

ATC

rabeprazole; oral

2.5

85.4

755

2267

K78

ICPC

Atrial fibrillation/flutter

3.6

85.3

423

861

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

4.7

85.1

321

505

R5140

NOMESCO Finland

Monitoring the use of the aid

2.7

84.3

643

1775

R06AX22

ATC

ebastine; oral

1.7

84.1

1940

8621

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

3.2

83.6

493

1148

R21

ICPC

Throat symptom/complaint

1.5

83.6

3698

19474

B01AF02

ATC

apixaban; oral

3.6

83.5

426

887

WX704

NOMESCO Finland

Intubation

2.6

83.4

665

1884

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

4.1

83.4

356

634

NGE35

NOMESCO Finland

Plastic repair of ligament of knee not using prosthetic material, anterior cruciate, arthroscopic

3.0

83.3

536

1325

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

4.0

82.8

364

666

WX702

NOMESCO Finland

Supraglottic ventilation device

3.1

82.8

500

1184

N06AX22

ATC

agomelatine; oral

3.6

82.6

414

850

N05AH03

ATC

olanzapine; systemic

2.2

82.5

945

3231

J01EA01

ATC

trimethoprim; systemic

1.6

82.4

2609

12668

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.6

82.3

415

856

M35.7

ICD-10 Finland

Hypermobility syndrome

4.7

82.3

309

484

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

82.2

2552

12325

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.5

81.8

425

898

M79.0

ICD-10 Finland

Rheumatism, unspecified

6.3

81.6

241

283

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.5

81.5

424

897

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.7

81.5

637

1784

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.1

81.2

510

1240

I50.9

ICD-10 Finland

Heart failure, unspecified

2.1

81.2

1062

3847

J05AB11

ATC

valaciclovir; oral

2.0

81.0

1256

4868

R96

ICPC

Asthma

2.4

81.0

769

2399

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.5

80.8

710

2125

NG4AA

NOMESCO Finland

Lower leg X-ray examination

4.1

80.8

348

625

N06BA04

ATC

methylphenidate; oral

2.7

80.6

624

1736

N06AB05

ATC

paroxetine; oral

2.5

80.6

719

2169

WX400

NOMESCO Finland

Inhalation anesthesy

2.7

80.5

597

1619

R05FB02

ATC

cough suppressants and expectorants

1.6

80.3

2923

14680

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.4

80.2

760

2366

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.3

80.2

849

2795

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

80.1

1209

4639

K59.09

ICD-10 Finland

Constipation, unspecified

3.2

80.1

471

1093

XF600

NOMESCO Finland

Bloodpressure measurement

2.7

80.0

605

1661

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

3.4

79.7

436

960

R07.3

ICD-10 Finland

Other chest pain

2.4

79.5

769

2421

H03AA01

ATC

levothyroxine sodium; systemic

1.7

79.3

1936

8734

WZA90

NOMESCO Finland

Other doctors statement

1.6

79.3

2782

13840

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.9

79.2

1434

5880

T74.1

ICD-10 Finland

Physical abuse

3.3

78.8

445

1003

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

5.3

78.6

266

371

F32

ICD-10 Finland

Depressive episode

2.2

78.4

910

3127

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

78.4

1080

3995

N06AX03

ATC

mianserin; oral

3.7

77.9

384

777

W10

ICD-10 Finland

Fall on and from stairs and steps

3.0

77.5

492

1207

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

6.0

77.3

236

290

B01AC04

ATC

clopidogrel; oral

2.4

77.2

715

2200

L09

ICPC

Arm symptom/complaint

3.0

77.1

487

1190

B01AF01

ATC

rivaroxaban; oral

3.5

76.8

402

855

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.9

76.6

1208

4709

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.7

76.5

367

726

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

30.5

76.4

113

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

3.7

76.1

371

744

L14

ICPC

Leg/thigh symptom/complaint

2.6

75.8

614

1754

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.6

75.7

617

1769

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

75.7

1255

4984

A29

ICPC

General symptom/complaint other

2.0

75.4

1041

3850

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.2

75.4

320

567

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

74.8

4855

27517

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.6

74.8

596

1687

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.9

74.6

512

1321

K08.3

ICD-10 Finland

Retained dental root

2.8

74.5

539

1439

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

11.0

74.3

156

104

S63.3

ICD-10 Finland

Traumatic rupture of ligament of wrist and carpus

5.0

74.2

265

393

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.3

73.8

737

2355

S10

ICPC

Boil/carbuncle

2.6

73.8

613

1777

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.2

73.8

803

2675

H25.1

ICD-10 Finland

Senile nuclear cataract

1.9

73.6

1223

4857

D07AD01

ATC

clobetasol; topical

1.9

73.5

1161

4524

M47.9

ICD-10 Finland

Spondylosis, unspecified

9.7

73.3

164

124

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.8

73.1

1565

6772

SPAT1252

SPAT

Overall medication plan or its review

2.8

72.8

514

1352

SGC10

NOMESCO Finland

Covering pulpa of tooth

1.8

72.8

1514

6491

R52.0

ICD-10 Finland

Acute pain

3.1

72.7

449

1080

SGA04

NOMESCO Finland

Very demanding opening and dilatation of root canal of tooth

1.8

72.6

1420

5966

J01CA08

ATC

pivmecillinam; oral

1.4

72.6

4457

24953

S60.0

ICD-10 Finland

Contusion of finger(s) without damage to nail

2.7

72.5

546

1495

TKC20

NOMESCO Finland

Catheterisation of bladder

2.5

72.5

618

1816

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

5.9

72.4

224

280

C07AB02

ATC

metoprolol; systemic

1.8

72.3

1414

5940

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

3.4

72.3

387

838

K30

ICD-10 Finland

Functional dyspepsia

2.1

71.9

964

3520

M01AE52

ATC

naproxen and esomeprazole; oral

5.1

71.9

252

366

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.9

71.8

493

1274

Z30.2

ICD-10 Finland

Sterilization

2.1

71.7

901

3202

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.3

71.6

738

2396

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

71.2

2974

15356

G04CA01

ATC

alfuzosin; oral

2.3

71.1

724

2336

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

3.4

71.0

377

811

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

6.4

70.9

206

237

S43.0

ICD-10 Finland

Dislocation of shoulder joint

3.0

70.9

445

1083

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.3

70.7

394

879

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

3.0

70.7

456

1130

C01CA24

ATC

epinephrine; parenteral

2.1

70.6

863

3029

K04.09

ICD-10 Finland

Pulpit UNS

2.5

70.6

621

1856

TAB00

NOMESCO Finland

Lumbar puncture

2.7

70.5

520

1406

R33

ICD-10 Finland

Retention of urine

2.4

70.4

659

2036

S29

ICPC

Skin symptom/complaint other

1.8

70.3

1505

6504

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.4

69.9

374

809

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

4.4

69.9

277

459

G04BD12

ATC

mirabegron; oral

3.1

69.7

435

1053

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.9

69.7

1093

4247

A04

ICPC

Weakness/tiredness general

1.7

69.7

1667

7452

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.7

69.6

1830

8407

N05BE01

ATC

buspirone; oral

3.7

69.6

332

654

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.5

69.5

2619

13195

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

69.5

575

1661

S20.2

ICD-10 Finland

Contusion of thorax

2.8

69.4

498

1322

N40

ICD-10 Finland

Hyperplasia of prostate

1.9

69.4

1207

4868

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

2.1

69.4

880

3137

R52.1

ICD-10 Finland

Chronic intractable pain

20.0

69.4

115

J01

ICD-10 Finland

Acute sinusitis

2.4

69.4

669

2100

M22.4

ICD-10 Finland

Chondromalacia patellae

2.9

69.2

460

1162

Z02.4

ICD-10 Finland

Examination for driving licence

2.1

69.2

868

3083

LCH00

NOMESCO Finland

Vacuum aspiration of products of conception from uterus

2.8

69.1

485

1270

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

3.2

68.8

399

918

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

5.2

68.8

236

335

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.6

68.7

539

1511

SPAT1053

SPAT

Memory test

2.5

68.7

606

1814

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.1

68.4

291

517

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.9

68.3

1152

4595

C05AA08

ATC

fluocortolone; rectal, topical

2.0

68.3

987

3715

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

5.6

68.1

217

282

R35

ICD-10 Finland

Polyuria

2.8

67.9

478

1255

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.9

67.6

452

1148

J46

ICD-10 Finland

Status asthmaticus

4.0

67.5

298

548

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

28.3

67.2

101

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

5.0

67.1

238

351

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.8

66.9

1418

6104

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.4

66.8

611

1865

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

2.0

66.6

964

3628

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.1

66.6

284

506

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

4.4

66.4

264

439

NGU20

NOMESCO Finland

Removal of internal fixation device from knee or lower leg

4.8

65.9

240

364

L29

ICPC

Musculoskeletal sympt/complt other

2.4

65.8

642

2025

R00.2

ICD-10 Finland

Palpitations

2.1

65.7

790

2751

M10.9

ICD-10 Finland

Gout, unspecified

3.4

65.4

352

765

D07AC13

ATC

mometasone; topical

1.5

65.4

2764

14265

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.0

65.3

408

990

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.9

64.8

1063

4192

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

64.8

2934

15365

R31

ICD-10 Finland

Unspecified haematuria

2.2

64.7

733

2484

M24.4

ICD-10 Finland

Recurrent dislocation and subluxation of joint

4.3

64.7

267

461

S63.5

ICD-10 Finland

Sprain and strain of wrist

2.6

64.5

511

1441

TLC02

NOMESCO Finland

Simple extraction of IUD

2.6

64.4

533

1541

N05AF03

ATC

chlorprothixene; systemic

3.5

64.4

335

709

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.0

64.2

920

3447

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.1

63.6

272

486

T78.4

ICD-10 Finland

Allergy, unspecified

2.3

63.6

675

2219

M01AH03

ATC

valdecoxib; oral

3.3

63.5

357

803

JAL21

NOMESCO Finland

Laparoscopic excision or destruction of lesion of peritoneum

3.9

63.4

285

533

P74

ICPC

Anxiety disorder/anxiety state

2.1

63.4

778

2733

J01MA06

ATC

norfloxacin; oral

1.9

63.4

1027

4031

L05

ICPC

Flank/axilla symptom/complaint

2.6

63.1

501

1413

LCA06

NOMESCO Finland

Biopsy of endometrium

2.2

63.1

726

2478

M01AB55

ATC

diclofenac, combinations; oral

3.3

63.1

353

791

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.1

63.1

795

2825

A99

ICPC

Disease/condition unspecnature/site

2.2

63.0

715

2426

Z50.1

ICD-10 Finland

Other physical therapy

3.1

63.0

378

891

A10BH01

ATC

sitagliptin; oral

3.2

62.9

370

858

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

3.9

62.9

282

526

XA402

NOMESCO Finland

ENMG

5.3

62.9

212

295

R03BA01

ATC

beclometasone; inhalant

1.8

62.8

1282

5446

M45

ICD-10 Finland

Ankylosing spondylitis

3.7

62.8

299

588

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.1

62.7

829

3005

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

6.0

62.7

189

229

H57.1

ICD-10 Finland

Ocular pain

2.9

62.7

414

1042

N17

ICPC

Vertigo/dizziness

2.0

62.6

923

3498

C08CA13

ATC

lercanidipine; oral

2.7

62.4

467

1272

SXA20

NOMESCO Finland

Local application of medicine to mouth

2.0

62.2

950

3648

R51.81

ICD-10 Finland

Facial pain NOS

4.2

62.2

258

448

3007

Kela drug reimbursment

Erenumab and fremanezumab

4.9

62.0

222

331

M43.1

ICD-10 Finland

Spondylolisthesis

5.1

61.8

214

307

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

4.5

61.8

242

397

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

2.4

61.7

584

1814

R5599

NOMESCO Finland

Other rehabilitation service

3.7

61.7

294

579

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.8

61.6

1148

4734

NH1AD

NOMESCO Finland

Ankle and foot CT

4.5

61.3

239

390

SPAT1240

SPAT

Therapeutic discussion

1.6

61.2

1907

9140

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

5.2

61.1

210

299

WZA00

NOMESCO Finland

Short statement of of health and health related matters

2.0

61.1

831

3049

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

61.0

710

2436

R06AE09

ATC

levocetirizine; oral

1.6

60.9

1757

8252

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.5

60.8

531

1582

N06AA12

ATC

doxepin; systemic

3.3

60.7

337

749

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

60.5

715

2468

P01BA02

ATC

hydroxychloroquine; oral

2.3

60.5

607

1940

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.7

60.5

470

1310

NBE45

NOMESCO Finland

Plastic repair of ligament of shoulder not using prosthetic material, arthroscopic

5.8

60.5

189

240

B01AB10

ATC

tinzaparin; parenteral

2.9

60.4

410

1051

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

60.2

1110

4558

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.9

60.2

966

3776

F61.0

ICD-10 Finland

Mixed personality disorders

3.5

60.2

315

670

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

60.2

1072

4350

M03BX01

ATC

baclofen; systemic

5.8

60.2

186

233

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.2

60.0

668

2247

J31.0

ICD-10 Finland

Chronic rhinitis

2.1

59.8

786

2840

P03

ICPC

Feeling depressed

1.6

59.6

1690

7897

L04AB04

ATC

adalimumab; parenteral

3.6

59.6

292

589

W17

ICD-10 Finland

Other fall from one level to another

2.4

59.4

551

1694

R06.5

ICD-10 Finland

Mouth breathing

2.2

59.4

640

2119

S83.4

ICD-10 Finland

Sprain and strain involving (fibular)(tibial) collateral ligament of knee

2.9

59.4

395

998

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

7.6

59.4

153

148

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.7

59.4

436

1175

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

9.2

59.3

136

108

Z00.0

ICD-10 Finland

General medical examination

1.6

59.3

1962

9539

R09

ICPC

Sinus symptom/complaint

1.8

59.2

1076

4396

S90.3

ICD-10 Finland

Contusion of other and unspecified parts of foot

2.9

59.0

399

1021

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.8

58.9

428

1145

EBA10

NOMESCO Finland

Surgical removal of tooth

1.5

58.7

2519

13002

207

Kela drug reimbursment

Chronic arrhythmias

2.3

58.6

612

1994

AN1

Coronary angiography

2.5

58.4

510

1518

G04BD08

ATC

solifenacin; oral

3.1

58.3

351

829

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.8

58.3

409

1070

R2110

NOMESCO Finland

Giving the first information

2.0

58.3

804

2965

A06AC51

ATC

ispaghula, combinations; systemic

2.7

58.3

435

1183

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

6.9

58.3

159

168

M04AA01

ATC

allopurinol; systemic

2.1

58.2

736

2618

N05CD07

ATC

temazepam; oral

2.1

58.2

755

2714

R07.0

ICD-10 Finland

Pain in throat

1.9

58.1

893

3434

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.9

58.0

1028

4164

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.1

58.0

734

2612

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

20.4

57.8

R60.9

ICD-10 Finland

Oedema, unspecified

3.1

57.7

348

823

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.3

57.2

232

394

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

3.6

57.1

280

565

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

6.5

57.1

162

181

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

5.5

57.1

185

246

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.5

56.9

506

1521

R10.0

ICD-10 Finland

Acute abdomen

2.8

56.9

395

1028

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

13.6

56.8

108

T82

ICPC

Obesity

2.6

56.8

443

1236

F51

ICD-10 Finland

Nonorganic sleep disorders

2.4

56.7

519

1585

P01

ICPC

Feeling anxious/nervous/tense

1.5

56.6

2156

10825

-50

ICPC

Medication/prescr/renewal

2.8

56.5

399

1049

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

56.5

8408

53785

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.4

56.4

511

1551

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.6

56.4

444

1246

G43.8

ICD-10 Finland

Other migraine

3.7

56.4

271

538

R03BA08

ATC

ciclesonide; inhalant

2.1

56.3

692

2432

SGB30

NOMESCO Finland

Other demanding filling of root channel of tooth

1.6

56.3

1504

6910

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.2

56.2

646

2202

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

56.2

2464

12757

SPAT1325

SPAT

Vaccination

1.4

56.2

3000

16175

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

5.2

56.0

189

264

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.6

55.9

275

557

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.8

55.9

263

513

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.8

55.9

1068

4434

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

1.8

55.8

1137

4820

ACC53

NOMESCO Finland

Release of ulnar nerve

8.1

55.5

137

124

M75.8

ICD-10 Finland

Other shoulder lesions

2.9

55.3

364

915

R01AD01

ATC

beclometasone; nasal

1.7

55.2

1410

6394

WX200

NOMESCO Finland

Interscalenous plexus blockade

8.3

55.2

134

118

E66

ICD-10 Finland

Obesity

2.6

55.2

438

1237

K59.1

ICD-10 Finland

Functional diarrhoea

2.5

55.1

485

1449

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

4.3

55.0

223

379

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

2.3

54.9

557

1789

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

54.8

3951

22487

K07.60

ICD-10 Finland

Snapping jaw

2.1

54.7

699

2497

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.6

54.5

436

1236

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.1

54.4

330

784

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

7.4

54.3

142

141

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.9

54.3

872

3406

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

4.2

54.2

228

402

SPAT1312

SPAT

General health counselling

1.4

54.0

4034

23084

DHB50

NOMESCO Finland

Turbinoplasty

3.1

54.0

326

772

R75

ICPC

Sinusitis acute/chronic

2.2

53.9

592

1975

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

2.5

53.9

481

1448

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

14.7

53.9

N05AX12

ATC

aripiprazole; systemic

2.0

53.9

739

2716

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022313) Gas panel - Capillary blood

3300

8490

2.20

322.26

3.6

3.1

—

(3019150) Specific gravity of Urine by Refractometry

14046

55643

1.50

318.16

4.5

3.4

1.0

kg/l

0.19

1948

8749

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2506

5745

2.45

316.13

3.2

2.9

0.3

0.4

u/ml

0.52

1444

3160

(3000492) Spirometry study

7275

24669

1.70

315.67

1.5

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

2547

5904

2.43

313.94

3.1

2.9

—

(3024354) Oxygen [Partial pressure] in Venous blood

5055

15453

1.87

309.43

3.5

2.8

4.6

kpa

0.14

4851

14966

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2934

7305

2.27

309.07

3.8

3.2

24.8

24.7

mmol/l

0.42

2728

6709

(3035350) Ketones [Presence] in Urine by Test strip

31434

127800

1.70

307.65

4.1

3.1

0.0

estimate

0.04

6470

23081

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

7120

20009

2.08

307.65

2.8

2.2

44.1

48.9

u/l

0.24

6045

17140

(3013650) Neutrophils [#/volume] in Blood by Automated count

38254

143561

2.17

307.65

9.3

7.9

4.3

4.0

e9/l

73.18

33777

125050

(3027801) Oxygen [Partial pressure] in Arterial blood

8322

22411

2.20

307.65

7.2

7.1

12.0

12.8

kpa

30.46

7935

21343

(3001122) Ferritin [Mass/volume] in Serum or Plasma

29568

117281

1.72

307.65

3.2

2.7

120.4

108.5

ug/l

9.19

27560

109587

(3021447) Carbon dioxide [Partial pressure] in Venous blood

6303

18732

1.94

307.65

4.2

3.4

5.9

5.8

kpa

7.57

6082

18210

(3002030) Lymphocytes/100 leukocytes in Blood

32834

121340

2.01

307.65

6.8

5.5

27.7

28.8

66.87

30806

113119

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

22537

73070

2.08

307.65

2.9

2.2

55.3

59.6

u/l

14.10

20897

67146

(40761511) CBC panel - Blood by Automated count

59366

291207

2.94

307.65

17.1

9.9

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

25475

85351

2.07

307.65

4.1

2.9

64.5

60.6

ng/l

0.10

16523

52154

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

30266

100083

2.27

307.65

6.5

5.0

1.2

mmol/l

5.58

27879

89684

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

11924

38972

1.84

307.65

3.0

2.5

2.4

mmol/l

14.62

10349

33831

(3019550) Sodium [Moles/volume] in Serum or Plasma

59140

275150

3.76

307.65

20.3

11.5

139.5

139.7

mmol/l

113.46

58276

266837

(3019309) Folate [Moles/volume] in Red Blood Cells

12586

39407

1.94

307.65

1.9

1.7

1178.6

1151.7

nmol/l

2.31

9761

29599

(3020630) Protein [Mass/volume] in Serum or Plasma

5799

15507

2.16

307.65

2.3

2.2

66.6

66.8

g/l

0.94

5291

14151

(3035941) MCH [Entitic mass]

61573

315566

3.65

307.65

27.1

15.3

30.3

30.2

34.07

61110

310873

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

55013

274044

1.79

307.65

4.6

4.0

4.6

4.7

mmol/l

131.93

51532

256560

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

15485

59401

1.57

307.65

1.3

1.5

1.7

u/ml

1.33

4085

16799

(3030467) Casts [#/volume] in Urine by Automated count

19204

62822

1.98

307.65

3.5

2.7

0.4

e6/l

0.32

14802

45795

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

8504

25162

1.99

307.65

2.6

2.3

7.2

8.1

umol/l

3.17

7172

21731

(40768797) Stomach Pathology biopsy report

10142

30655

1.97

307.65

1.3

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

8353

21946

2.26

307.65

1.9

1.6

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

8653

25602

1.99

307.65

7.4

6.5

104.3

104.7

mmol/l

8.81

8460

25025

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

17312

50998

2.19

307.65

1.9

1.6

1.0

1.2

mg/l

4.16

13221

37972

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

6455

19030

1.96

307.65

2.2

2.1

0.2

g/l

0.40

5975

17676

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

8299

21811

2.26

307.65

1.9

1.6

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4542

12150

2.14

307.65

8.8

9.1

1.5

1.4

5.69

4515

12061

(3026361) Erythrocytes [#/volume] in Blood

61580

315650

3.65

307.65

27.3

15.4

4.5

4.6

e12/l

299.87

60548

305972

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2483

4780

2.93

307.65

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3993

10759

2.11

307.65

9.4

9.5

—

(3009261) Glucose [Presence] in Urine by Test strip

31723

129578

1.69

307.65

4.1

3.1

0.0

estimate

0.47

6399

23085

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

8331

22420

2.20

307.65

7.2

5.1

kpa

3.75

7945

21356

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

41901

186153

1.70

307.65

3.6

2.7

53.2

41.1

u/l

108.43

39476

175024

(3012544) pH of Venous blood

6555

19405

1.95

307.65

4.2

3.5

7.4

0.36

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

59250

273340

3.99

307.65

19.0

10.0

22.2

22.7

mg/l

3.39

51022

205833

(3020682) Albumin/Creatinine [Ratio] in Urine

19190

70368

1.72

307.65

4.2

4.0

10.5

8.4

mg/mmol

5.84

12333

44661

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

26467

95509

1.90

307.65

2.1

1.8

96.0

96.9

pmol/l

2.15

14398

50016

(3023520) Reticulocytes [#/volume] in Blood

5847

16295

2.07

307.65

2.5

71.9

68.6

e9/l

7.72

4417

12256

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4505

11585

2.22

307.65

3.5

3.0

1.7

1.6

mmol/l

0.71

3319

8342

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

21271

66825

2.13

307.65

2.3

2.0

196.3

215.5

u/l

1.79

20048

62554

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

9765

34039

1.68

307.65

2.0

1.7

1.5

1.4

32.51

8500

30625

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

13382

38489

2.15

307.65

1.3

1.2

10.6

11.2

u/ml

0.35

5092

15573

(3000494) Fungus identified in Specimen by Culture

8217

27353

1.75

307.65

1.5

1.4

—

(3020779) Urea [Moles/volume] in Serum or Plasma

6245

17414

2.08

307.65

7.6

6.7

9.8

9.4

mmol/l

2.79

5923

16574

(3004789) Transferrin [Mass/volume] in Serum or Plasma

10717

31572

2.04

307.65

2.6

2.3

2.4

g/l

0.12

9911

29139

(3022096) Basophils/100 leukocytes in Blood

31137

112276

2.03

307.65

6.8

5.5

0.7

4.05

29236

104516

(3009542) Hematocrit [Volume Fraction] of Blood

52385

262319

1.56

307.65

19.1

11.3

40.1

40.2

1.89

38516

199403

(3012095) Magnesium [Moles/volume] in Serum or Plasma

11775

32815

2.19

307.65

3.5

2.9

0.8

mmol/l

29.93

11012

30452

(3027945) Reticulocytes/100 erythrocytes in Blood

7748

22505

2.02

307.65

2.5

1.8

1.7

17.26

6824

19889

(3003458) Phosphate [Moles/volume] in Serum or Plasma

9474

26303

2.15

307.65

5.9

5.4

1.0

mmol/l

5.96

8853

24477

(3032080) INR in Blood by Coagulation assay

28163

86524

2.42

307.65

9.8

7.4

1.2

inr

0.76

8418

26069

(3019198) Lymphocytes [#/volume] in Blood

35001

128028

2.12

307.65

6.6

5.3

2.0

1.9

e9/l

0.37

31324

113081

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

7439

21519

2.02

307.65

3.7

2.8

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

10029

28919

2.08

307.65

2.7

2.3

21.8

23.9

36.54

8576

24617

(3002582) Erythrocytes [#/volume] in Urine

20742

69426

1.95

307.65

3.6

2.8

84.2

96.8

e6/l

0.42

16282

51869

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

4559

11777

2.21

307.65

6.4

7.0

24.8

24.6

mmol/l

1.41

4522

11656

(3015377) Calcium [Moles/volume] in Serum or Plasma

21983

76805

1.88

307.65

3.3

2.8

2.4

mmol/l

1.06

19370

66996

(3033658) Prothrombin time (PT) actual/Normal

18301

56872

2.08

307.65

4.2

3.2

91.7

91.4

0.72

17803

55330

(3026493) Urate [Moles/volume] in Serum or Plasma

19406

60149

2.11

307.65

2.7

2.3

2418.2

4961.3

umol/l

19.08

16888

52788

(3048689) Calprotectin [Mass/mass] in Stool

9601

32119

1.76

307.65

2.5

2.4

140.9

125.5

ug/g

2.66

7677

25033

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

5262

14982

2.01

307.65

3.9

3.7

91.3

87.8

ng/l

1.40

4609

12940

(3001604) Monocytes [#/volume] in Blood

34205

123161

2.14

307.65

6.6

5.3

0.6

e9/l

56.69

30076

106854

(3031040) Bacteria [#/volume] in Urine by Automated count

41892

168132

2.09

307.65

5.2

3.7

1024.0

1299.8

e6/l

0.42

465

2430

(3000475) Leukocytes [#/volume] in Synovial fluid

2382

4031

3.33

307.65

1.7

1.6

14973.0

11232.1

e6/l

2.31

1686

3000

(3013115) Eosinophils [#/volume] in Blood

35269

128306

2.15

307.65

6.8

5.6

0.2

e9/l

9.53

31501

112845

(3018010) Neutrophils/100 leukocytes in Blood

32405

119595

2.00

307.65

6.6

5.3

57.7

56.7

37.19

30505

111958

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

54604

272200

1.74

307.65

4.5

3.9

1.4

1.5

mmol/l

230.79

50840

254022

(3016502) Oxygen saturation in Arterial blood

7464

20032

2.19

307.65

7.5

95.5

95.8

3.51

7190

19225

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

26936

102107

1.78

307.65

2.5

2.1

75.5

961.2

nmol/l

0.50

24537

92675

(3037467) Urinalysis macro (dipstick) panel - Urine

43485

179472

2.06

307.65

5.0

3.7

—

(3000963) Hemoglobin [Mass/volume] in Blood

61582

315785

3.64

307.65

27.4

15.4

134.7

137.0

g/l

270.48

61121

311112

(3021589) Normoblasts [#/volume] in Blood

28015

114297

1.62

307.65

11.2

8.0

0.0

e9/l

1.45

23120

94050

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

48779

192968

2.70

307.65

8.5

6.0

77.1

74.9

u/l

20.26

46419

180727

(3024731) MCV [Entitic volume]

61576

315618

3.65

307.65

27.2

15.3

91.2

90.5

230.41

61108

310915

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

34974

121607

2.30

307.65

6.1

4.9

10.6

11.5

umol/l

28.33

33099

114585

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

17357

54103

2.05

307.65

2.5

2.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5918

16780

2.03

307.65

2.5

2.1

6.5

7.9

ug/l

4.42

5124

14717

(40758558) Short blood count panel - Blood

17314

59710

1.82

307.65

7.1

5.9

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4386

12094

2.07

307.65

1.5

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

4473

12685

2.01

307.65

7.6

6.7

24.6

24.5

mmol/l

1.90

4190

11759

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1938

2624

4.15

307.65

1.8

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2833

6457

2.48

307.65

2.4

2.2

453.2

539.2

ug/l

0.61

2652

5970

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

54421

255733

2.21

307.65

16.2

9.6

84.3

84.9

ml/min/173m2

7.25

46928

205699

(40768804) Tissue Pathology biopsy report

24820

105414

1.48

307.65

2.1

2.0

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3587

8858

2.30

307.65

4.4

3.8

24.1

mmol/l

0.15

3227

7884

(3044941) Cell count panel - Synovial fluid

1605

2577

3.48

307.65

1.5

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

48394

233796

1.58

307.65

21.4

12.7

13.8

13.5

190.31

47704

228388

(3021960) Folate [Moles/volume] in Serum or Plasma

15659

51160

1.91

307.65

1.6

1.5

20.2

20.3

nmol/l

0.30

13686

43986

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

14099

41244

2.13

307.65

1.3

1.2

33.3

35.9

iu/ml

0.41

4266

13004

(3003396) Base excess in Arterial blood by calculation

8321

22429

2.20

307.65

7.2

7.1

1.0

mmol/l

0.14

6561

17318

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

32352

115319

2.11

307.65

4.4

3.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

52833

262357

1.64

307.65

4.1

3.6

1.4

1.2

mmol/l

307.65

48939

243683

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

55981

277980

1.92

307.65

5.1

4.3

2.7

2.8

mmol/l

134.11

52092

258725

(3014007) Fractional oxyhemoglobin in Arterial blood

4584

12103

2.17

307.65

8.9

9.3

93.6

94.1

4.37

4564

12062

(42870588) Differential panel, method unspecified - Blood

24477

79984

2.11

307.65

6.4

5.4

—

(3019069) Monocytes/100 leukocytes in Blood

32168

116791

2.04

307.65

7.1

5.7

8.5

0.01

30331

109350

(3009343) pH of Capillary blood

4675

12005

2.23

307.65

3.5

3.0

7.4

1.55

674

1592

(3028026) IgM [Mass/volume] in Serum or Plasma

4557

12979

2.00

307.65

1.8

1.2

1.3

g/l

2.43

4172

11905

(3020564) Creatinine [Moles/volume] in Serum or Plasma

60219

293230

3.64

307.65

20.7

11.8

77.2

75.5

umol/l

25.89

60198

293065

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

11002

35544

1.85

307.65

3.2

2.6

3.3

2.9

e6/l

2.46

5829

18937

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4318

11279

2.18

307.65

1.8

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

59243

276154

3.79

307.65

20.5

11.6

4.0

3.9

mmol/l

62.38

58277

267252

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2547

5416

2.65

307.65

1.8

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

20666

73671

1.80

307.65

3.5

3.1

7.6

8.1

mmol/l

1.69

17487

62495

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

22632

82817

1.78

307.65

3.4

2.8

33.6

32.5

u/l

0.66

21467

78546

(4010399)

5390

16120

1.92

307.65

1.5

1.4

—

(3023368) Bacteria identified in Blood by Culture

19711

54812

2.42

307.65

4.7

3.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

11518

34598

2.01

307.65

2.7

2.3

12.8

14.5

umol/l

2.50

10701

32023

(3014111) Lactate [Moles/volume] in Serum or Plasma

6707

17072

2.30

307.65

6.7

6.8

1.4

1.3

mmol/l

0.25

6466

16450

(3042936) Bacteria identified in Isolate by Culture

11890

28046

2.64

307.65

2.3

1.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

5707

16428

2.00

307.65

3.0

2.6

195.4

199.0

ng/l

0.19

5122

14896

(3012516) Albumin [Mass/volume] in Urine

18480

66510

1.74

307.65

3.4

3.2

416.0

371.9

mg/l

0.58

12139

41635

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

5912

13757

2.50

307.65

1.7

1.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

47861

189352

2.59

307.65

4.9

3.4

12.3

10.5

mm/h

123.49

45081

174958

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4538

12118

2.14

307.65

8.9

9.2

0.7

0.79

4511

12042

(3022217) INR in Platelet poor plasma by Coagulation assay

9419

26037

2.16

307.65

28.4

20.4

1.4

1.3

inr

1.60

1308

3924

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

11835

38039

1.87

307.65

3.0

2.5

1.1

e6/l

0.39

6645

21283

(3006315) Basophils [#/volume] in Blood

34350

123757

2.15

307.65

6.6

5.3

0.0

e9/l

8.44

30184

107322

(3018095) Leukocytes [#/volume] in Urine

23776

84146

1.88

307.65

4.2

3.2

68.8

96.2

e6/l

7.32

17394

56699

(36304419) Bacteria [Presence] in Urine

18941

61464

1.99

307.65

3.4

2.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

4727

12183

2.22

307.65

3.5

3.0

5.2

5.1

kpa

3.64

4383

11228

(3026782) Osmolality of Urine

13722

43786

1.92

307.65

3.0

2.5

533.7

555.9

mosm/kgh2o

18.54

11852

36786

(3005719) IgG [Mass/volume] in Serum or Plasma

5860

16820

2.01

307.65

2.7

2.4

10.2

10.8

g/l

19.38

5340

15422

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

13419

41794

1.97

307.65

4.1

3.2

361.4

625.1

ng/l

5.77

9818

29894

(3044889) 12 lead EKG panel

42447

176556

1.97

307.65

4.1

3.2

—

(3010813) Leukocytes [#/volume] in Blood

61591

315715

3.67

307.65

27.3

15.4

7.0

6.6

e9/l

285.81

60585

306010

(3000850) Epithelial cells [#/volume] in Urine

15114

46750

2.02

307.65

2.8

2.3

6.1

5.6

e6/l

1.98

13366

40303

(3044640) Blood type and Crossmatch panel - Blood

22719

72582

2.12

307.65

2.6

2.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

7412

20208

2.15

307.65

2.3

2.0

356.5

386.1

nmol/l

25.74

6825

18625

(3007164) IgA [Mass/volume] in Serum or Plasma

13780

50308

1.65

307.65

1.5

1.4

2.4

2.3

g/l

3.80

8449

31521

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

46819

209096

1.88

307.65

4.4

3.8

14.7

14.6

pmol/l

2.14

43267

191134

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

32616

112573

2.22

307.65

7.2

5.6

1.2

mmol/l

9.88

27752

94236

(3000991) Gas panel - Venous blood

6149

16126

2.21

307.65

8.2

8.1

—

(3026008) Bacteria identified in Urine by Culture

19553

68921

1.81

307.65

3.3

2.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

7903

23586

1.96

307.65

3.8

4.0

234.4

239.5

u/l

2.22

7422

22337

(3006504) Eosinophils/100 leukocytes in Blood

31995

116115

2.04

307.65

6.8

5.4

2.8

2.9

3.96

30047

108051

(3013826) Glucose [Moles/volume] in Serum or Plasma

38740

141173

2.31

307.65

5.3

4.0

6.7

6.6

mmol/l

2.11

36699

128822

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

18497

57256

2.09

307.65

3.2

2.7

1361.6

1286.7

ng/l

1.26

15727

48112

(3021601) Nitrite [Presence] in Urine by Test strip

31364

128331

1.68

307.65

5.3

4.3

0.0

estimate

0.02

6617

23748

(3022145) Colonoscopy Study observation

8003

26728

1.74

307.65

1.4

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

60053

295916

3.25

307.65

12.7

8.2

27.7

26.4

u/l

25.29

58609

285124

(3021788) Differential panel - Synovial fluid

1901

3051

3.50

307.65

1.6

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

9892

25205

2.37

307.65

2.0

1.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

23980

101080

1.49

307.65

4.3

3.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

4858

12471

2.24

307.65

2.2

2.0

—

(3029937) Albumin [Presence] in Urine by Test strip

17271

68243

1.54

307.65

4.6

3.4

0.0

estimate

0.31

6371

22912

(3019060) Gas panel - Arterial blood

4930

12768

2.22

307.65

5.0

4.7

—

(3037522) Nuclear Ab [Titer] in Serum

11014

33076

2.00

307.65

1.4

1.3

482.2

558.6

titre

3.61

2154

6547

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3939

9885

2.27

307.65

8.7

9.6

24.3

mmol/l

0.04

3677

9196

(40760892) CBC W Ordered Manual Differential panel - Blood

15251

58849

1.56

307.65

4.8

4.0

—

(3007461) Platelets [#/volume] in Blood

61556

315260

3.65

307.65

27.3

15.4

257.6

252.0

e9/l

77.55

60690

306409

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

18065

56629

2.05

307.65

2.5

2.0

3.0

2.8

mg/l

15.46

15532

48158

(3011397) Hemoglobin [Presence] in Urine by Test strip

15411

57256

1.63

307.65

4.0

3.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

52860

243580

2.17

307.65

6.2

4.9

40.0

38.8

mmol/mol

133.14

49595

226537

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

13550

49717

1.63

307.65

1.7

1.6

33054864.0

39780350.2

pmol/l

0.56

11354

41531

(3024561) Albumin [Mass/volume] in Serum or Plasma

29338

97414

2.22

307.65

5.1

4.0

35.7

36.2

g/l

38.82

27401

89813

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

53975

250596

2.25

307.65

5.3

4.4

1.9

2.1

mu/l

2.45

50342

231336

(3015736) pH of Urine

25108

98267

1.67

307.65

3.7

2.9

5.6

5.8

0.34

(3002032) Base excess in Venous blood by calculation

6321

18648

1.96

307.65

4.2

3.4

1.8

mmol/l

0.13

5173

15210

(3018418) pH of Serum or Plasma

20262

64642

2.06

307.65

4.4

3.5

7.4

3.46

3975

12216

(3013512) EKG study

17309

67274

1.57

307.65

4.1

3.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

54629

262165

2.06

307.65

4.8

4.0

6.0

5.8

mmol/l

180.14

50390

241641

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

11926

32783

2.23

307.65

2.0

1.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

10600

32671

1.94

307.65

2.1

1.9

30.1

29.6

10.43

10267

31664

(3002173) Hemoglobin [Mass/volume] in Arterial blood

6839

18647

2.14

307.65

8.0

7.9

122.0

123.0

g/l

3.44

6608

17909

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2848

7024

2.29

306.51

2.1

1.9

2.2

ug/l

0.53

2498

6188

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2371

5460

2.44

296.01

1.4

279.3

285.8

ug/g

0.59

1414

3023

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3402

9217

2.09

291.53

1.5

1.6

13.7

14.4

u/ml

0.06

302

(3017181) Myelocytes/100 leukocytes in Blood

5971

19556

1.75

291.36

4.1

0.9

0.03

1729

4743

(3002179) Metamyelocytes/100 leukocytes in Blood

5530

17753

1.78

288.58

3.9

3.8

0.6

0.73

1303

3370

(3015171) Extractable nuclear Ab [Units/volume] in Serum

3396

9232

2.08

288.40

1.3

1.2

0.9

0.8

u/ml

0.11

338

712

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1225

1969

3.47

284.01

6.6

5.7

11.4

11.3

mg/l

0.24

1110

1826

(3008898) HLA-B27 [Presence]

3270

8861

2.08

279.79

1.1

—

(3019225) pH of Specimen

6431

21856

1.69

274.09

4.5

3.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

5689

18728

1.74

271.65

4.1

0.1

0.15

1597

4408

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2493

6119

2.29

270.62

2.8

2.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

3272

8983

2.06

270.37

1.7

1.8

1.6

1.4

g/l

8.95

2809

7664

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1822

3844

2.65

270.33

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1822

3847

2.65

269.93

1.3

1.2

—

(3025941) Bacteria identified in Stool by Culture

4612

14358

1.82

264.91

1.3

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2606

6622

2.21

260.93

2.1

1.9

3.0

g/l

0.98

2066

5083

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

17758

75882

1.40

258.62

4.8

4.5

3.1

2.7

ug/l

0.64

15904

68543

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2155

5079

2.38

255.62

1.3

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2723

7123

2.15

254.08

2.1

1.9

7.5

7.2

g/l

9.52

2115

5188

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2719

7115

2.15

253.48

2.1

1.9

—

(3025159) Blasts/100 leukocytes in Blood

5375

17752

1.73

252.78

4.1

0.1

0.3

0.99

1370

3675

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2713

7103

2.15

252.58

2.1

1.9

3.8

g/l

0.61

2024

4916

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

5478

18247

1.71

249.79

2.8

2.4

67.4

69.4

ml/min/173m2

2.73

2309

6843

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2359

5910

2.24

243.91

2.3

2.0

0.7

0.8

g/l

0.69

2040

5053

(40761535) Cells panel - Urine sediment

5469

18328

1.70

243.66

4.0

3.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

8880

33597

1.53

241.03

1.7

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2547

6626

2.16

240.65

2.1

1.9

10.0

10.4

g/l

4.67

2155

5508

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2705

7261

2.09

236.24

1.6

245.1

299.6

titre

0.49

120

294

(3012501) Base excess in Blood by calculation

1949

4564

2.39

234.16

4.0

3.5

2.4

mmol/l

0.22

1288

3010

(3013290) Carbon dioxide [Partial pressure] in Blood

1949

4566

2.39

233.94

4.0

3.5

5.0

kpa

1.43

1911

4449

(3027315) Oxygen [Partial pressure] in Blood

1957

4594

2.38

233.88

4.0

3.5

8.7

8.8

kpa

1.45

1919

4476

(3041096) Erythrocytes [Presence] in Urine by Automated

16965

72936

1.38

232.86

3.6

2.8

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2181

5389

2.27

232.66

2.1

1.8

38.1

38.0

g/l

0.36

1895

4578

(3020891) Body temperature

2860

7893

2.04

232.27

5.3

4.6

—

(3010421) pH of Blood

2167

5344

2.27

232.19

4.0

3.4

7.4

2.88

1913

4448

(3028707) Methadone [Presence] in Urine by Screen method

2035

4891

2.33

231.01

3.6

2.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1885

4378

2.41

230.43

1.7

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

15743

67049

1.39

227.64

1.7

1.6

1.5

1.3

mmol/l

74.58

13309

56773

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2121

5245

2.26

225.75

2.1

1.9

0.0

g/l

0.80

1941

4768

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

39841

195049

1.33

224.90

3.5

3.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1822

4223

2.41

223.63

1.7

1.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2608

7105

2.06

218.90

1.7

1.2

g/l

13.62

2465

6764

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

1202

2259

2.96

218.71

1.6

1.5

56.4

54.9

0.49

771

1435

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2537

6875

2.07

215.86

1.8

1.7

0.2

g/l

5.53

2395

6521

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1971

4826

2.28

214.45

2.2

1.9

0.0

g/l

0.53

1793

4366

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

613

715

4.75

211.23

2.1

2.2

122.3

152.9

umol/l

1.06

317

342

(3034860) Kappa light chains.free [Mass/volume] in Serum

2170

5581

2.18

210.39

3.2

2.6

79.9

66.6

mg/l

0.19

1728

4522

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2167

5571

2.18

210.30

3.2

2.6

44.2

42.0

mg/l

0.13

1721

4518

(1616796) Gas panel - Central venous blood

1880

4553

2.31

209.61

3.6

3.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1939

4771

2.27

208.56

2.2

1.9

0.0

g/l

0.00

1785

4362

(3018405) Lactate [Moles/volume] in Arterial blood

2511

6880

2.05

207.42

4.4

4.0

1.4

mmol/l

0.35

2468

6757

(3005322) IgE [Units/volume] in Serum or Plasma

4824

16294

1.68

207.14

1.4

1.3

228.3

241.1

u/ml

0.31

4456

15109

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2640

7406

2.00

204.63

1.7

1.6

3.5

7.7

iu/ml

0.56

559

1471

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

5014

17206

1.65

202.59

2.4

2.3

22.9

23.5

au/ml

0.13

301

1155

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4657

15681

1.68

202.07

1.3

45.9

49.2

au/ml

0.38

180

671

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1393

2977

2.61

201.23

1.7

1.6

—

(3017732) Neutrophils [#/volume] in Blood

5021

17277

1.65

200.67

2.7

2.6

4.2

4.1

e9/l

3.52

3985

13595

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2092

5411

2.16

199.92

3.1

2.6

2.2

4.0

ratio

0.72

179

427

(3017446) Testosterone [Moles/volume] in Serum or Plasma

5449

19177

1.61

199.17

2.5

2.1

12.2

12.6

nmol/l

1.95

4826

17235

(3047181) Lactate [Moles/volume] in Blood

2412

6651

2.03

195.70

6.1

5.3

1.3

mmol/l

0.06

2138

5862

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

5266

18521

1.61

192.65

4.3

3.1

1.2

mmol/l

3.72

4663

15970

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

13203

55933

1.38

191.08

1.7

1.6

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3129

9572

1.84

187.84

3.3

2.5

1.4

1.2

11.97

3114

9523

(3023183) Ammonium ion [Moles/volume] in Plasma

1621

3875

2.33

185.83

2.5

33.5

32.9

umol/l

0.31

1370

3265

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2966

8955

1.86

185.41

2.1

1.8

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2228

6133

2.03

181.40

1.2

1.1

—

(40761536) Microorganisms panel - Urine sediment

5986

21996

1.55

181.29

4.5

3.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2531

7306

1.94

180.69

1.8

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3047

9386

1.82

178.74

3.3

2.5

0.7

1.46

2941

8982

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

7527

29146

1.48

177.86

8.4

5.5

—

(3036489) Thrombin time

2844

8585

1.86

177.73

2.0

1.9

21.5

21.2

0.92

2429

7335

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

14009

60486

1.35

177.56

4.2

4.0

22.2

21.9

0.83

6052

28428

(3004119) Hemoglobin [Mass/volume] in Venous blood

3883

12879

1.70

177.16

3.7

3.0

129.0

131.5

g/l

8.49

3763

12616

(36660697) Celiac disease serology panel - Serum

5724

20940

1.55

176.52

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

1707

4281

2.22

175.39

2.7

2.3

16.4

16.8

3.29

866

2225

(3043409) Potassium [Moles/volume] in Arterial blood

2155

5964

2.02

172.84

4.7

4.3

3.9

mmol/l

0.28

2041

5579

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1785

4615

2.16

170.46

1.4

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2709

8169

1.86

169.67

2.0

1.7

—

(3002256) Pathology report gross observation

8218

32673

1.44

168.61

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1410

3309

2.37

168.17

1.5

1.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2117

5895

2.01

166.91

1.4

1.5

17.8

14.2

iu/ml

0.42

148

(40760888) Immunoglobulin light chains.free panel - Serum

1637

4133

2.21

165.49

3.2

2.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1905

5116

2.08

165.30

3.0

2.7

24.7

24.6

mmol/l

0.23

1668

4518

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4637

16394

1.60

164.83

3.2

3.4

4.5

4.6

pmol/l

6.96

4141

14660

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1113

2362

2.62

162.83

1.6

1.4

—

(3011288) Drugs identified in Urine by Screen method

2750

8448

1.82

162.38

4.3

2.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

5732

21365

1.52

161.62

1.4

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1559

3902

2.23

160.84

1.5

—

(3024928) Oxygen saturation in Venous blood

1601

4053

2.20

160.79

3.5

3.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

3126

10066

1.74

157.83

2.0

39.2

39.5

u/l

0.26

2787

9044

(3010144) Erythrocytes [#/volume] in Synovial fluid

872

1653

2.92

156.29

1.4

123743.1

78485.8

e6/l

1.07

606

1118

(3028626) Oxygen [Partial pressure] in Capillary blood

1665

4342

2.14

155.54

2.9

2.6

8.3

kpa

0.06

1540

4030

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2401

7158

1.88

155.47

2.1

94.4

92.3

4.21

2220

6594

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

5604

20953

1.52

155.39

3.5

3.8

16.6

18.2

ug/l

0.20

4496

16274

(3014765) Yersinia sp identified in Stool by Organism specific culture

2331

6892

1.89

154.74

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

2332

6914

1.89

153.51

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2308

6840

1.89

152.10

1.2

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

1310

3125

2.33

150.70

2.0

1.7

1.8

mmol/l

0.58

1282

3041

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2214

6504

1.90

149.75

2.6

2.4

181.6

180.1

0.31

2078

6156

(3030905) Polymorphonuclear cells [#/volume] in Blood

1697

4530

2.09

149.42

3.3

3.2

4.3

4.0

e9/l

4.68

1692

4524

(3023419) Bacteria identified in Sputum by Culture

1036

2225

2.58

148.09

2.6

2.3

—

(3026470) Cobalt [Mass/volume] in Blood

551

800

3.81

146.70

2.0

1.9

4.1

3.5

ug/l

0.62

488

700

(3037756) Immunofixation for Serum or Plasma

1444

3641

2.21

146.32

1.6

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1213

2832

2.38

146.21

1.5

1.3

—

(3025577) Chromium [Mass/volume] in Blood

537

774

3.84

144.34

2.1

2.0

2.3

2.4

ug/l

0.13

446

655

(3024980) IgG subclass 4 [Mass/volume] in Serum

1394

3515

2.21

141.22

1.5

1.6

0.7

0.8

g/l

4.58

1033

2649

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1065

2380

2.48

140.66

1.5

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

1082

2448

2.45

139.34

1.6

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2214

6671

1.85

138.54

1.3

25.7

40.7

u/ml

1.44

102

440

(3039000) Anion gap in Blood

1693

4648

2.03

138.42

7.2

6.3

11.3

mmol/l

0.04

1533

4178

(3018572) Chloride [Moles/volume] in Blood

1693

4649

2.03

138.34

7.2

6.3

105.0

105.3

mmol/l

1.74

1534

4179

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1106

2545

2.41

137.48

1.5

1.4

—

(3003338) MCHC [Mass/volume]

47731

245257

1.28

137.08

23.5

13.2

332.1

333.2

g/l

108.53

47411

243277

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1565

4194

2.08

136.33

1.2

203.8

116.8

titre

0.31

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3440

11863

1.63

134.23

2.4

2.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1712

4775

2.00

134.08

1.5

1.3

—

(3022806) Fractional oxyhemoglobin in Capillary blood

1090

2527

2.39

133.36

1.9

1.7

89.7

90.2

1.96

1071

2488

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1296

3250

2.22

132.98

3.2

3.0

0.8

nmol/l

0.71

996

2482

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2193

6687

1.83

132.12

2.5

2.4

3.7

3.6

g/l

1.32

2080

6356

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1737

4903

1.97

131.59

2.3

2.1

129.6

132.4

g/l

3.99

1243

3657

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1570

4312

2.03

128.16

1.5

—

(3037121) Protein [Mass/volume] in Urine

2319

7268

1.78

127.78

2.9

0.3

g/l

0.03

1000

3100

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1309

3355

2.17

127.46

1.3

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

2964

9969

1.66

127.23

3.0

2.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

851

1788

2.64

126.89

1.5

32.3

33.6

0.39

515

1127

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

898

1948

2.55

125.88

1.7

1.5

—

(1002224) Polysomnography panel

3290

11404

1.62

125.54

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1535

4233

2.02

123.92

5.9

5.0

1767.4

1091.8

iu/ml

0.28

221

578

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1793

5241

1.91

122.81

2.1

1.8

195.3

pmol/l

0.00

1702

5004

(4035726)

4990

19113

1.47

121.48

1.4

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1953

5897

1.85

121.22

1.3

537.2

516.9

mg/l

0.30

1862

5625

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2016

6176

1.82

119.53

1.3

7.9

8.9

u/ml

0.25

273

999

(3021901) Oxygen saturation in Capillary blood

1382

3718

2.07

119.10

2.9

2.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

2094

6503

1.80

118.80

1.2

96.4

123.7

titre

1.05

173

635

(3049717) Cytology report of Urine Cyto stain

2429

7881

1.72

118.75

2.5

2.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2652

8841

1.68

117.49

1.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

846

1849

2.53

116.86

1.6

1.4

1.5

1.4

promille

0.98

658

1424

(3034770) Mitochondria Ab [Titer] in Serum

2050

6361

1.80

116.60

1.2

871.3

1015.1

titre

0.34

206

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2797

9504

1.65

115.21

1.6

1.7

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1978

6096

1.81

115.00

1.3

3.6

6.2

u/ml

1.51

177

669

(3042631) Mycobacterium sp identified in Specimen

1020

2458

2.30

114.67

2.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

947

2209

2.38

114.35

1.4

6.5

6.9

g/l

2.23

655

1524

(3024139) IgG subclass 3 [Mass/volume] in Serum

945

2207

2.37

113.81

1.4

0.4

g/l

2.41

657

1529

(3028192) IgG subclass 2 [Mass/volume] in Serum

945

2208

2.37

113.70

1.4

2.8

3.1

g/l

6.99

656

1526

(4062490)

945

2216

2.36

112.81

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2673

9038

1.65

112.15

5.7

4.5

1.8

1.6

9.22

2482

8491

(3042517) Benzodiazepines panel - Urine

252

226

6.15

111.94

2.6

3.0

—

(3045414) Leukocytes [Presence] in Urine

3099

10886

1.59

111.66

2.0

1.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2991

10427

1.60

111.19

3.8

3.1

25.1

25.3

mmol/l

1.02

2877

10130

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2955

10271

1.61

111.18

1.1

3.2

8.5

u/ml

0.91

172

(3003181) Sodium [Moles/volume] in Urine

1188

3107

2.12

110.03

1.4

1.3

62.5

64.1

mmol/l

0.55

924

2474

(3007930) Methemoglobin/Hemoglobin.total in Blood

2624

8892

1.65

109.11

5.9

4.6

0.9

2.81

2445

8351

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1728

5195

1.85

108.61

1.2

3.8

3.7

mmol/l

0.37

1620

4891

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1636

4846

1.88

107.60

1.2

12.3

15.4

u/ml

0.15

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2408

8009

1.68

107.44

1.9

1.6

38.0

42.1

nmol/l

12.83

2351

7842

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

844

1933

2.42

105.97

1.7

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1724

5226

1.84

105.58

1.3

1.4

33.9

28.9

e6/l

0.18

1335

4026

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2555

21786

0.63

104.96

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

1631

4867

1.86

104.87

1.3

1.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1721

5235

1.83

104.24

1.3

1.4

1284.7

2600.7

e6/l

0.79

1404

4234

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

9970

43845

1.30

102.39

2.9

0.7

0.8

ug/l

8.17

6365

27793

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1996

6394

1.74

101.84

2.1

11.3

10.5

mg/l

2.27

1860

5993

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

777

1753

2.45

100.68

1.7

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1656

5040

1.83

100.11

1.3

1.2

40.7

42.1

u/ml

0.12

159

477

(3016879) Cocaine [Presence] in Urine

3337

12229

1.53

99.70

2.9

1.9

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1048

2729

2.13

98.12

1.5

1.3

—

(44790048)

872

2105

2.29

97.67

1.6

1.4

—

(44790047)

872

2105

2.29

97.67

1.6

1.4

—

(40768443) Skin Pathology biopsy report

2957

10599

1.56

97.48

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1621

4942

1.82

97.44

1.3

1.2

5.7

6.1

u/ml

0.05

107

411

(44806118)

871

2105

2.29

97.31

1.6

1.4

—

(44790049)

871

2105

2.29

97.31

1.6

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2062

6757

1.70

97.03

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

1173

3205

2.03

97.01

3.1

1.2

1.5

1.50

888

2431

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1015

2622

2.15

96.93

1.5

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1013

2621

2.14

96.36

1.5

1.3

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

953

2412

2.19

95.65

1.3

25.2

30.5

nmol/l

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1011

2622

2.14

95.61

1.5

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1020

2659

2.13

95.24

1.5

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1380

4025

1.90

95.00

3.2

2.8

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1022

2669

2.12

95.00

1.5

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1170

3220

2.02

94.90

1.3

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

646

1385

2.58

92.74

1.6

1.4

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

1019

2694

2.10

91.84

1.2

1.1

1.9

2.1

iu/ml

0.14

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1815

5839

1.73

91.15

3.0

2.8

1.6

1.4

mg/l

9.22

1657

5381

(3000764) Benzodiazepines [Presence] in Urine

3507

13235

1.48

90.90

2.9

1.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1569

14519

0.58

90.25

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

692

1557

2.46

90.21

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

692

1557

2.46

90.21

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

692

1557

2.46

90.21

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

897

2270

2.19

90.07

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1118

3085

2.01

90.04

1.3

0.3

0.2

nmol/l

0.55

166

(3028300) Cannabinoids [Presence] in Urine

3527

13355

1.48

89.89

2.9

1.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

7081

30198

1.32

89.74

4.5

4.1

31.6

32.2

4.58

5187

20829

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

739

1721

2.38

89.61

3.7

4.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

2447

8568

1.59

88.97

1.4

1.3

9.6

9.5

u/l

0.08

2014

7063

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1120

3107

2.00

88.90

1.3

0.8

1.5

nmol/l

0.77

1072

2994

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2183

7454

1.63

87.84

1.4

1.3

—

(3027008) Opiates [Presence] in Urine

3507

13332

1.47

87.56

2.9

1.8

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

354

550

3.55

86.26

2.2

1.8

58.8

55.0

ug/l

0.41

346

534

(3023420) DNA double strand Ab [Units/volume] in Serum

954

2526

2.09

85.66

1.6

34.7

30.8

iu/ml

0.24

129

(3020961) Endomysium IgA Ab [Titer] in Serum

3375

12820

1.47

84.52

1.1

169.6

207.8

titre

0.38

361

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2673

9676

1.54

84.11

4.2

3.6

50.2

47.5

6.50

2634

9579

(3013139) Helicobacter pylori Ag [Presence] in Stool

4339

17292

1.41

84.00

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

568

1205

2.60

83.28

1.9

1.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1272

3780

1.87

82.77

1.3

1.2

3.8

3.7

u/ml

0.05

550

1704

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1129

3229

1.94

82.29

2.7

2.5

967.8

5135.9

u/ml

0.67

165

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1303

3932

1.84

80.86

1.3

1.2

3.7

3.6

u/ml

0.03

423

1391

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1011

2802

2.00

80.47

1.3

—

(4306422)

1270

3814

1.85

80.01

1.2

—

(3027944) Amphetamines [Presence] in Urine

3416

13170

1.45

79.12

2.7

1.8

—

(3044927) Protein electrophoresis panel - Urine

705

1707

2.28

78.51

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

463

915

2.79

77.42

1.1

5.3

3.4

iu/ml

0.76

(4198724)

545

1191

2.53

75.46

2.3

2.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

786

2033

2.14

74.90

3.6

3.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

754

1927

2.16

74.00

3.2

3.0

59.3

57.1

1.42

486

1178

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1245

3822

1.81

73.16

1.1

—

(3022621) pH of Urine by Test strip

4076

16457

1.39

72.72

3.1

2.6

—

(3008295) Osmolality of Serum or Plasma

749

1923

2.15

72.70

1.4

1.5

279.0

280.7

mosm/kgh2o

1.04

578

1519

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1208

3685

1.82

72.44

1.1

122.5

116.6

8.16

1096

3323

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

698

1743

2.21

72.42

2.9

2.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2469

9084

1.51

71.95

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

3713

14785

1.40

71.82

1.4

1.3

24.8

26.8

iu/l

3.24

3172

12837

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

923

2580

1.98

71.80

2.2

1.8

25.0

26.6

mg/l

0.35

258

674

(3048929) Epstein Barr virus Ab [Presence] in Serum

2382

8702

1.52

71.73

1.3

1.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

706

1785

2.19

71.13

2.2

2.6

0.5

0.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

713

1812

2.18

70.95

1.8

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

461

957

2.66

70.52

1.6

1.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

454

943

2.66

69.39

1.5

5.1

3.3

1.43

220

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

456

951

2.65

69.17

1.6

1.4

—

(3024263) Appearance of Synovial fluid

461

972

2.62

68.50

1.7

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

530

1200

2.44

68.33

1.5

1.4

5.6

5.7

u/l

0.23

458

997

(3036670) Protein [Mass/volume] in Synovial fluid

284

448

3.49

67.88

1.3

1.2

40.6

39.0

g/l

0.85

144

252

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3219

12628

1.42

67.63

3.0

2.5

0.3

e6/l

0.01

3119

12251

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1048

10003

0.57

67.46

1.7

1.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

509

1138

2.47

67.36

1.4

1.3

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

768

2054

2.07

67.28

1.8

23.9

21.8

ug/l

0.24

753

2010

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

502

1116

2.48

67.21

1.4

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

3576

14334

1.39

66.41

1.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

392

771

2.80

66.19

2.0

1.9

9.0

9.6

mg/l

1.20

319

612

(3004616) Nuclear Ab [Presence] in Serum

967

2830

1.89

65.94

1.3

—

(3011985) Renin [Units/volume] in Plasma

1042

3133

1.84

65.43

1.5

1.6

70.9

59.4

mu/l

0.76

928

2826

(3011412) CD3 cells [#/volume] in Blood

770

2088

2.04

65.07

2.3

2.4

1.3

1.1

e9/l

2.62

457

1223

(3020876) Protein [Mass/time] in 24 hour Urine

643

1628

2.18

64.61

2.0

1.9

1.4

1.0

g/24h

0.72

109

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1173

3673

1.77

64.59

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1504

5060

1.65

64.00

1.4

12.5

21.5

u/ml

2.61

107

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

795

2198

2.00

63.78

1.2

58.1

60.2

u/l

0.36

559

1438

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1513

5106

1.64

63.62

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

896

2595

1.91

63.03

1.1

67.1

18.4

au/ml

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

348

664

2.89

61.99

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

492

1127

2.41

61.96

1.5

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1898

6809

1.55

61.96

1.5

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1507

5116

1.63

61.91

1.2

—

(40762814) Titanium [Mass/volume] in Blood

169

187

4.98

61.89

2.4

3.2

4.7

ug/l

1.25

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

877

2548

1.90

61.14

1.1

67.3

67.4

au/ml

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

656

1716

2.11

60.87

1.3

1.2

1.1

u/ml

0.10

328

690

(3017315) Amylase [Enzymatic activity/volume] in Urine

481

1103

2.41

60.45

1.4

1.2

306.9

357.6

u/l

0.38

450

1027

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

957

2879

1.84

60.02

1.4

342.1

297.8

pmol/l

0.68

761

2246

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

900

2655

1.87

59.95

1.1

97.7

95.0

2.07

832

2488

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

659

1742

2.09

59.56

1.2

69.4

219.8

titre

2.23

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

322

601

2.95

59.55

1.7

1.6

136.2

130.1

au/ml

0.06

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

589

1489

2.18

59.45

1.9

1.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1365

4567

1.66

59.33

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

660

1749

2.08

59.27

1.2

124.7

207.0

titre

2.24

104

288

(3002523) Influenza virus A Ag [Presence] in Specimen

1364

4566

1.66

59.17

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

875

2571

1.88

59.00

2.0

2.2

32.4

32.7

1.28

867

2552

(3009015) Lactate [Moles/volume] in Synovial fluid

129

113

6.28

58.68

1.3

1.1

5.9

6.2

mmol/l

0.15

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1053

3286

1.77

58.68

1.3

34.8

30.0

u/l

0.46

940

2846

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1220

10823

0.61

58.60

1.5

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1021

3158

1.79

58.59

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1418

4807

1.63

58.59

1.3

1.2

276.0

254.5

u/ml

1.79

936

3129

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1235

4038

1.69

58.49

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

732

2032

1.99

58.12

1.5

1.4

4060.6

3291.1

e6/l

0.22

531

1451

(3003434) Protein [Mass/volume] in Pleural fluid

795

2276

1.93

57.88

1.5

1.4

32.8

32.7

g/l

0.05

732

2036

(3039162) Centromere protein B Ab [Units/volume] in Serum

983

3022

1.80

57.55

1.3

1.2

50.9

51.5

u/ml

0.02

195

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1428

12169

0.64

57.40

1.4

1.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

671

1814

2.04

57.23

1.2

1.1

—

(3051651) Icteric interference index of Serum or Plasma

464

1074

2.38

57.20

3.8

3.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

679

1845

2.03

57.13

1.4

1.3

1.5

1.4

nmol/l

1.01

610

1666

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

261

438

3.28

57.13

1.3

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

672

1819

2.04

57.12

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

671

1816

2.04

57.06

1.2

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1140

3672

1.72

56.98

3.2

3.0

477.5

679.0

u/ml

0.38

1041

3309

(46235355) HIV 1 and 2 tests - Meaningful Use set

13007

62192

1.19

56.58

2.0

1.9

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1084

3452

1.74

56.39

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

669

1817

2.03

56.37

1.5

1.4

55303.7

52329.0

e6/l

0.11

392

1058

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1552

5432

1.58

56.34

2.4

127.9

96.5

ug/min

1.49

908

3301

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

664

1799

2.04

56.31

1.2

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

744

2102

1.96

56.26

1.4

1.6

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

663

1796

2.04

56.25

1.2

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1157

3756

1.71

56.24

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

381

807

2.60

56.23

1.7

1.6

2.0

umol/l

1.11

359

752

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

664

1801

2.04

56.15

1.2

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3571

14701

1.35

56.01

1.1

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

863

2570

1.86

55.89

1.3

1.4

—

(3023410) Appearance of Cerebral spinal fluid

807

2351

1.90

55.85

1.3

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1255

4174

1.67

55.81

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

485

5507

0.48

55.24

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

1520

5326

1.58

54.92

2.3

1.9

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1376

4708

1.62

54.81

1.4

113.6

109.4

u/ml

0.46

323

1106

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

984

3080

1.77

54.31

1.1

1.5

g/l

7.07

888

2792

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1593

5663

1.56

54.11

1.3

1.2

—

(3014271) Vancomycin [Susceptibility]

376

808

2.57

53.99

3.2

2.7

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

683

1900

1.99

53.96

1.8

2.0

18.3

18.7

nmol/l

0.66

644

1804

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

486

1187

2.26

53.25

1.2

85.8

86.8

u/l

0.08

420

1038

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1857

6860

1.50

52.96

3.0

3.2

625.6

1757.9

u/ml

0.66

1565

5875

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

384

843

2.51

52.87

1.4

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1346

11416

0.64

52.87

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

384

844

2.51

52.75

1.4

1.3

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

565

1477

2.11

52.59

2.8

2.9

27.8

26.9

ug/l

0.06

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1347

11408

0.64

52.55

1.4

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

440

1036

2.34

52.33

1.6

15.1

5.5

nmol/l

0.36

361

868

(4268621)

858

2607

1.82

52.20

2.4

2.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

7041

31947

1.24

52.09

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1348

11386

0.64

51.93

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1344

11356

0.64

51.85

1.4

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

666

1863

1.97

51.83

1.2

1.1

19.0

72.4

u/ml

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

471

1150

2.26

51.66

1.2

23.7

20.7

u/l

0.67

397

996

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

513

1301

2.18

51.47

1.4

13.0

12.6

u/l

0.59

495

1261

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1698

6206

1.52

50.91

1.2

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

828

2512

1.82

50.64

7.0

9.1

7.7

7.2

mmol/l

1.00

677

2030

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

764

2259

1.87

50.61

2.8

3.3

6.6

6.9

nmol/l

0.04

723

2191

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

829

2520

1.82

50.38

1.2

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

591

1599

2.04

50.37

2.9

2.1

—

(3051611) Lipemic interference index of Serum or Plasma

718

2084

1.90

50.29

3.6

3.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

600

1636

2.02

50.09

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2319

9049

1.42

49.94

2.0

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

550

1454

2.09

49.79

1.5

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

566

1514

2.06

49.71

2.3

2.5

522.1

508.7

e6/l

0.23

472

1266

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

595

1624

2.02

49.55

1.2

—

(3019977) pH of Arterial blood

437

1055

2.28

49.21

3.0

2.3

7.4

0.00

144

364

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

568

1530

2.05

48.99

2.1

2.0

—

(4034850)

2088

8036

1.44

48.44

12.4

7.8

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1200

4093

1.62

48.43

1.1

12.4

11.6

au/ml

0.10

289

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

555

1489

2.06

48.38

1.1

8.4

8.5

iu/ml

0.03

151

394

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

706

2065

1.89

48.35

1.2

1.1

38.8

44.3

mg/l

1.82

582

1731

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

7298

33480

1.22

48.34

1.7

1.8

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

686

1988

1.91

48.29

1.1

247.8

261.7

mg/l

0.76

594

1747

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

515

1344

2.11

48.19

1.5

1.6

23.2

24.4

u/ml

0.18

281

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

771

2324

1.83

48.15

1.1

—

(3012441) Differential panel - Pleural fluid

620

1737

1.97

48.09

1.5

1.4

—

(4094501)

1733

6440

1.49

48.02

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

605

1684

1.98

47.78

2.1

2.0

74.5

72.8

1.98

571

1622

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

221

375

3.25

47.68

1.5

1.6

0.4

ug/l

1.29

152

233

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

371

846

2.42

47.32

2.4

2.5

130.9

146.3

au/ml

0.22

112

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1065

9275

0.62

47.13

1.4

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

4587

20020

1.28

47.09

1.2

130.8

147.8

iu/ml

1.76

1673

7777

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

910

8215

0.60

46.96

1.4

1.5

—

(3005033) Fetal Nuchal fold Thickness US

1065

9251

0.63

46.59

1.4

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1099

9467

0.63

46.31

1.4

1.5

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

440

1096

2.21

46.14

2.0

1.8

138.4

138.7

0.03

416

1027

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

469

1200

2.16

46.12

1.1

—

(3002619) Bacteria identified in Specimen by Culture

218

376

3.19

45.90

1.3

1.1

—

(3045788) Cell count panel - Pleural fluid

567

1567

2.00

45.70

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

10721

51214

1.18

45.66

1.7

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

542

1475

2.03

45.54

2.4

2.5

0.2

e9/l

1.05

473

1267

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

2029

7866

1.43

45.25

1.1

5.0

5.3

u/ml

0.10

224

1181

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

564

1564

1.99

45.04

1.3

469.3

526.7

u/l

0.23

532

1477

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

623

1791

1.92

44.94

1.2

1.3

2.1

mmol/l

0.13

567

1668

(40768806) Pleura Pathology biopsy report

613

1753

1.93

44.90

1.6

1.5

—

(3016244) Insulin [Units/volume] in Serum or Plasma

558

1546

1.99

44.68

3.3

3.1

29.5

27.2

mu/l

0.58

526

1450

(3037692) Legionella sp identified in Specimen by Organism specific culture

287

592

2.67

44.67

1.5

1.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

390

936

2.30

44.56

2.9

3.0

7.9

8.2

mg/l

0.32

301

756

(3045424) Erythrocytes [Presence] in Urine

1201

4183

1.59

44.54

1.5

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1732

6535

1.47

44.52

1.8

1.9

14.3

18.7

iu/l

0.15

611

2527

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

588

1664

1.95

44.38

2.0

13.5

14.7

1.32

281

761

(3016038) Potassium [Moles/volume] in Urine

456

1172

2.15

44.37

1.3

1.1

35.0

34.0

mmol/l

0.38

374

1027

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

244

462

2.91

44.22

1.4

1.3

36.9

39.8

0.46

159

313

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

395

959

2.27

43.98

1.8

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

394

956

2.27

43.93

1.8

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

394

956

2.27

43.93

1.8

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

394

956

2.27

43.93

1.8

1.7

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

340

771

2.43

43.92

1.8

1.5

28.7

29.7

umol/l

1.02

330

737

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

468

1221

2.11

43.89

1.3

13.6

15.3

u/l

0.64

428

1125

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

660

1951

1.87

43.83

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

609

1757

1.91

43.50

1.2

1.3

—

54.4

u/ml

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

453

1172

2.13

43.38

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

461

1206

2.11

42.95

1.6

1.3

nmol/l

0.23

360

981

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

591

1698

1.92

42.74

1.2

4.1

10.5

u/ml

1.37

129

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

807

2562

1.74

42.54

1.1

1.0

—

(3003694) ABO and Rh group [Type] in Blood

16477

81691

1.15

42.54

1.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

611

1779

1.90

42.49

1.2

87.4

63.0

u/ml

0.80

(3013166) Neutrophils/100 leukocytes in Synovial fluid

267

545

2.70

42.40

1.4

54.2

53.2

0.14

221

473

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3341

14197

1.31

41.90

2.5

2.3

5714.4

6280.7

u/l

0.46

1160

6036

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

610

1784

1.89

41.87

1.2

41.6

41.1

u/ml

0.02

135

(3020717) Zinc [Moles/volume] in Serum or Plasma

424

1084

2.16

41.84

1.5

1.3

21.0

28.0

umol/l

4.67

408

1024

(3038026) Centromere Ab [Units/volume] in Serum

621

1830

1.87

41.67

1.2

50.9

42.8

u/ml

0.17

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

527

1469

1.98

41.54

1.2

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

578

1666

1.91

41.42

1.3

6.4

6.3

mmol/l

0.34

534

1541

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

203

358

3.12

41.35

1.2

—

(4027681)

559

1598

1.93

41.04

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

476

1285

2.04

40.93

1.7

1.8

100.4

97.8

0.80

439

1185

(3000093) Morphology [Interpretation] in Blood Narrative

671

2042

1.81

40.74

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

359

867

2.28

40.51

3.8

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1255

4517

1.54

40.41

1.4

1.3

23.0

24.4

u/l

0.74

1020

3742

(3009466) Valproate [Moles/volume] in Serum or Plasma

1080

3774

1.58

39.55

4.9

5.4

345.8

379.0

umol/l

11.12

943

3274

(3010503) CD19 cells [#/volume] in Blood

473

1295

2.01

39.20

2.5

2.6

0.3

0.4

e9/l

0.67

454

1270

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

479

1318

2.00

39.16

1.1

3.6

6.5

nmol/l

0.94

258

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1122

3985

1.56

38.34

1.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

331

792

2.30

38.18

2.0

1.9

158.8

160.3

0.08

312

747

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

443

1196

2.04

38.13

1.3

402.6

344.0

titre

0.13

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

551

1608

1.89

38.12

2.4

2.5

758.8

697.6

e6/l

0.93

234

659

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

462

1277

2.00

37.34

1.6

1.5

7.5

6.0

u/l

0.76

236

581

(3004451) EKG impression Narrative

352

874

2.22

37.32

1.3

1.2

—

(3045142) Bone marrow Pathology biopsy report

682

2144

1.76

37.26

1.3

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

420

1122

2.06

37.18

1.7

1.5

2469853.1

1748602.5

iu/ml

0.45

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

644

1993

1.78

37.08

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

2805

11839

1.32

36.86

1.6

296.9

311.6

mu/l

1.05

2517

10653

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

429

1160

2.04

36.79

1.3

117.9

72.6

titre

0.48

116

(40757494) Bilirubin.total [Moles/volume] in Blood

398

1047

2.10

36.66

2.0

16.6

16.9

umol/l

0.04

(3047189) Immunofixation for 24 hour Urine

310

735

2.32

36.52

1.8

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

8057

38209

1.18

36.51

2.2

2.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

328

802

2.25

36.06

2.5

2.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

519

1519

1.88

35.64

1.7

3.7

3.6

mg/l

0.30

489

1451

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

306

730

2.31

35.57

2.0

1.9

—

(3045716) Anion gap in Serum or Plasma

349

884

2.18

35.33

2.9

2.4

9.4

9.2

mmol/l

0.23

243

639

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

302

719

2.31

35.27

2.0

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

302

720

2.31

35.17

2.0

1.9

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

282

652

2.38

35.11

1.8

1.5

1087.9

20742.8

u/ml

1.30

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1048

3741

1.55

35.06

1.6

1.7

—

(3017704) Immunofixation for Urine

370

966

2.11

34.77

1.5

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

297

708

2.31

34.60

1.2

0.7

0.4

g/l

0.25

(3036071) Salmonella sp Ab [Titer] in Serum

307

748

2.26

34.06

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

371

979

2.09

33.95

1.2

1.1

—

(4015189)

225

473

2.62

33.95

2.4

2.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

336

854

2.17

33.76

1.2

0.3

g/l

2.66

261

675

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

350

905

2.13

33.72

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

183

346

2.91

33.40

1.8

1.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

486

1424

1.88

33.31

1.1

1.0

1.1

u/l

0.47

206

634

(21494815) CD4 cells/100 lymphocytes in Specimen

626

1989

1.74

33.04

2.2

2.1

41.1

42.1

0.19

267

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

8812

42429

1.16

32.73

2.3

2.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

816

2803

1.61

32.17

2.5

2.8

1447.8

685.7

u/ml

0.29

780

2607

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

388

1066

2.01

31.97

1.2

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

574

1796

1.76

31.95

1.1

290.6

455.0

mg/l

0.50

522

1617

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

174

328

2.92

31.95

2.5

2.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

111

4.61

31.68

1.8

1.6

43.7

49.0

umol/l

0.76

111

(3006442) Creatine [Moles/volume] in Serum or Plasma

561

1753

1.77

31.38

1.6

1.4

65.1

71.8

umol/l

1.51

150

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

288

709

2.24

31.26

2.4

2.7

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

311

792

2.16

31.15

1.2

115.7

107.7

2.18

279

717

(4146454)

689

2286

1.66

31.13

2.9

2.8

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

730

2463

1.64

30.93

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

326

849

2.12

30.91

1.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

253

600

2.32

29.91

1.6

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

240

556

2.38

29.85

1.3

1.2

120.5

125.6

nmol/l

0.17

176

417

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

574

1848

1.71

29.00

1.2

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

544

1726

1.74

28.94

11.8

12.3

0.6

mmol/l

2.06

488

1593

(3034426) Prothrombin time (PT)

305

797

2.11

28.72

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2998

13190

1.26

28.47

2.8

52.1

40.1

u/ml

1.00

2885

12755

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

342

942

2.00

28.07

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

302

795

2.09

27.93

1.1

93.4

91.0

0.60

140

382

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

275

699

2.17

27.75

1.3

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

294

768

2.11

27.73

1.1

98.3

91.0

2.04

136

372

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

9.52

27.60

1.5

1.7

245.7

214.1

nmol/l

0.22

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

448

1362

1.81

27.50

1.2

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

454

1387

1.80

27.44

2.7

3.4

118.4

108.3

nmol/l

0.25

443

1364

(3012565) Volume of 24 hour Urine

385

1116

1.90

27.36

2.1

1986.2

2032.8

0.35

344

991

(3010375) cycloSPORINE [Mass/volume] in Blood

315

851

2.04

27.25

29.9

25.3

116.9

115.3

ug/l

0.14

262

708

(3037556) Urate [Mass/volume] in Serum or Plasma

231

549

2.32

27.24

1.4

1.3

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

10.50

27.23

1.7

1.6

239.0

358.0

nmol/l

0.40

(21494434) Karyotype in Bone marrow

523

1672

1.72

27.13

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1253

4891

1.42

27.00

2.6

1.9

0.9

0.8

nmol/l

4.89

1060

4125

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

546

1770

1.70

26.96

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

301

803

2.06

26.92

1.2

112.0

110.6

0.37

263

725

(3023383) Lactate [Moles/volume] in Pleural fluid

213

493

2.38

26.61

1.3

3.4

3.6

mmol/l

0.38

192

451

(3035880) pH of Pleural fluid

336

940

1.97

26.46

1.3

—

(3007463) Buprenorphine [Presence] in Urine

4.74

26.41

6.2

8.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

398

1181

1.86

26.39

1.4

1.7

—

(3006245) CD3-CD19+ cells/100 cells in Blood

311

850

2.02

26.12

2.1

2.0

9.4

10.0

0.39

289

789

(3029634) Reagin Ab [Titer] in Serum by VDRL

1048

3986

1.45

26.00

2.1

6.2

7.2

titre

0.16

117

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

304

827

2.02

25.86

2.0

1.9

28.9

29.0

0.00

286

780

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

517

1671

1.71

25.83

1.1

1.2

1.1

ratio

0.66

185

587

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

255

649

2.16

25.70

1.1

—

(3028433) Virus identified in Specimen by Culture

257

658

2.15

25.53

1.2

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

328

922

1.96

25.51

2.2

1.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

240

598

2.21

25.45

3.3

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

240

598

2.21

25.45

3.3

2.2

—

(3017569) Oxygen content in Arterial blood

316

878

1.98

25.39

2.3

2.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

457

1436

1.75

25.21

1.7

1.8

—

(3026250) Tacrolimus [Mass/volume] in Blood

313

871

1.98

25.05

39.0

33.5

7.6

7.3

ug/l

1.48

284

800

(3000034) Microalbumin [Mass/volume] in Urine

604

2056

1.62

24.84

2.9

55.8

55.5

mg/l

0.01

438

1450

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

564

1892

1.64

24.57

1.2

1.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

295

813

2.00

24.27

2.1

2.2

1.0

ug/l

0.04

276

760

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

486

1573

1.70

24.20

1.0

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

488

1582

1.70

24.17

1.0

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

121

218

3.05

24.07

1.8

1.7

mg/l

0.16

183

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

378

1138

1.83

24.02

4.5

7.3

1093.4

3672.5

u/ml

0.56

288

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

172

381

2.48

23.62

5.9

6.2

65.8

72.7

2.36

139

301

(43055442) Apixaban [Mass/volume] in Serum or Plasma

111

193

3.16

23.37

1.6

107.1

112.4

ug/l

0.18

148

(40768441) Liver Pathology biopsy report

437

1387

1.74

23.34

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

133

259

2.83

23.26

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

213

526

2.23

23.12

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

409

1278

1.76

23.05

1.2

27.3

8.0

u/ml

0.77

133

(3006922) Hepatitis E virus Ab [Presence] in Serum

519

1736

1.65

22.91

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

328

960

1.88

22.76

2.3

2.1

89.3

105.3

ug/min

0.18

235

(3019420) Tryptase [Mass/volume] in Serum or Plasma

422

1336

1.74

22.76

1.4

1.5

8.2

7.6

ug/l

0.22

387

1196

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

198

479

2.28

22.55

1.2

341.7

335.6

pmol/l

0.04

138

359

(3036180) Methadone [Presence] in Urine

6.63

22.54

2.4

2.5

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

391

1215

1.77

22.47

1.3

63.8

65.7

0.14

139

(3008116) Ketones [Moles/volume] in Urine by Test strip

180

418

2.37

22.43

1.6

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1062

4166

1.41

22.34

1.1

173.5

1064.2

iu/ml

1.25

281

900

(3016228) CD19 cells/100 cells in Blood

306

883

1.91

22.17

2.1

2.0

8.7

8.6

0.03

293

866

(40761539) Cells [Type] in Urine sediment by Light microscopy

209

522

2.20

22.12

1.2

—

(21494755) Public health laboratory ask at order entry panel

5597

35144

0.86

21.83

1.3

—

(3001186) Copper [Moles/volume] in Serum or Plasma

213

542

2.16

21.58

1.4

1.2

16.5

16.7

umol/l

0.18

196

477

(3028717) Thiamine [Mass/volume] in Blood

110

201

3.01

21.45

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

396

1255

1.74

21.32

1.6

1.7

2.7

2.4

u/field

0.27

285

899

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

410

1315

1.72

21.18

2.7

40.9

39.3

0.59

144

445

(4024509)

603

2136

1.56

21.10

1.7

1.5

—

(3006576) Bicarbonate [Moles/volume] in Blood

263

733

1.98

21.07

6.1

6.2

24.8

25.2

mmol/l

0.71

238

661

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

353

1086

1.79

21.01

2.0

2.3

42.7

270.9

ug/l

1.48

340

1029

(3029075) Extractable nuclear Ab panel - Serum

250

685

2.01

20.98

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

466

1555

1.65

20.82

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

228

608

2.06

20.57

1.9

167.2

883.7

e6/l

0.98

125

303

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

242

661

2.02

20.50

2.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

934

3639

1.42

20.47

1.3

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

101

181

3.07

20.35

1.2

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

164

3.19

20.29

1.6

1.8

mg/l

0.14

103

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

190

476

2.20

20.03

1.3

1.1

93.9

84.3

1.05

126

(3052592) Norovirus Ag [Presence] in Stool

156

358

2.40

20.00

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

314

947

1.83

19.95

1.4

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

183

452

2.23

19.94

1.2

1.3

257.1

240.1

ug/l

0.04

103

232

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

314

948

1.82

19.89

1.4

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

180

442

2.24

19.89

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

199

511

2.14

19.77

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

199

511

2.14

19.77

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

199

511

2.14

19.77

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

199

511

2.14

19.77

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

882

3423

1.42

19.77

1.7

1.8

4202.2

3922.1

titre

0.05

153

(21494814) CD8 cells/100 lymphocytes in Specimen

293

867

1.86

19.76

2.1

2.0

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

196

501

2.15

19.70

1.3

1.2

111.8

105.7

1.47

188

473

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

112

218

2.83

19.69

1.7

1.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

189

477

2.18

19.59

1.2

1.1

82.6

73.6

0.81

121

(3020491) Glucose [Moles/volume] in Blood

534

1873

1.57

19.55

1.8

1.7

7.0

6.4

mmol/l

4.58

411

1386

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

177

3.05

19.52

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

306

924

1.82

19.39

12.8

8.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

6202

38359

0.88

19.29

1.7

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

373

1200

1.71

19.12

1.1

100.5

95.0

2.86

308

944

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

3225

20935

0.84

19.00

1.4

—

(3036603) Volume of Urine

449

1521

1.63

18.98

1.6

1962.6

2011.8

0.18

376

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

160

3.13

18.93

1.6

1.1

0.8

mg/l

0.26

102

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

160

3.13

18.93

1.6

2.3

2.2

mg/l

0.05

102

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

160

3.13

18.93

1.6

3.4

4.3

mg/l

0.46

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

160

3.13

18.93

1.6

1.8

3.2

mg/l

1.07

106

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

160

3.13

18.93

1.6

1.5

2.1

mg/l

0.38

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

160

3.13

18.93

1.6

0.9

1.8

mg/l

0.96

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

160

3.13

18.93

1.6

1.4

2.3

mg/l

1.03

108

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

160

3.13

18.93

1.6

2.8

mg/l

1.14

110

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

160

3.13

18.93

1.6

1.8

1.9

mg/l

0.06

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

243

685

1.95

18.92

2.9

3.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

205

547

2.06

18.53

1.1

—

(44813793)

535

1904

1.55

18.42

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

177

447

2.18

18.36

1.2

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

136

305

2.45

18.34

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

300

917

1.80

18.32

1.1

507.8

607.5

ng/l

0.10

219

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

191

500

2.10

18.14

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

449

1540

1.61

18.09

1.2

—

(3000012) Reticulocyte production index

365

1187

1.69

18.04

1.4

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

351

1132

1.71

17.88

1.5

1.6

6.2

5.7

mmol/24h

0.23

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

243

2387

0.56

17.68

18.5

18.8

5274.6

2380.7

nmol/l

0.32

230

2283

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

290

891

1.79

17.45

1.1

—

(3006270) Folate [Moles/volume] in Blood

547

1982

1.52

17.41

1.2

1.1

376.9

374.6

nmol/l

0.09

476

1686

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

298

925

1.77

17.34

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

141

3.16

17.16

1.1

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

345

3068

0.62

17.00

1.4

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

131

301

2.39

16.85

1.5

1.6

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

386

3334

0.63

16.73

1.5

1.6

8.4

7.4

mmol/l

6.02

258

1954

(3008536) Aspergillus sp Ab [Presence] in Serum

149

365

2.25

16.65

2.0

2.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

232

2264

0.56

16.52

13.8

13.4

751.2

1274.9

nmol/l

0.63

222

2187

(40768446) Kidney Pathology biopsy report

282

875

1.77

16.46

1.7

1.6

—

(40762365) Oxygen content in Arterial blood by calculation

128

295

2.39

16.37

3.2

2.4

14.7

15.0

ml/dl

0.43

118

276

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

345

1140

1.67

16.14

1.2

1.1

84.2

78.6

u/l

0.52

285

891

(3043410) Blood group antigens tested for on Red Blood Cells

217

624

1.91

16.06

1.7

1.6

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

278

866

1.77

16.03

1.4

14.6

14.7

pmol/l

0.11

238

732

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

344

1140

1.66

15.93

1.2

1.1

22.3

19.6

u/l

0.54

266

866

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

489

1765

1.53

15.90

1.1

—

(3048879) Bone marrow aspiration report

192

531

1.99

15.87

1.8

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

301

965

1.72

15.74

2.3

2.5

56.2

52.5

umol/l

1.06

241

817

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1192

5038

1.31

15.67

1.1

1.5

2.4

u/ml

2.19

321

1239

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

132

3.12

15.66

1.1

1.3

124.2

101.1

ug/l

0.51

(3038177) Helicobacter pylori Ab [Presence] in Serum

1116

4675

1.32

15.64

1.2

—

(3006462) Nitrate [Presence] in Urine

351

1176

1.64

15.60

3.3

2.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1392

6013

1.28

15.49

1.1

1.4

1.6

u/ml

0.27

591

2335

(3003888) Timothy IgE Ab [Units/volume] in Serum

1261

5389

1.29

15.27

1.1

4.8

5.5

u/ml

0.75

646

2748

(4211845)

377

1294

1.60

15.24

3.2

2.7

—

(3041806) Other cells [#/volume] in Blood by Manual count

153

1646

0.51

15.21

1.8

1.4

—

(3003129) Base excess in Capillary blood by calculation

186

518

1.98

15.11

1.8

1.5

0.9

0.2

mmol/l

1.22

174

487

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

166

444

2.06

15.03

1.4

1.6

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

107

3.34

15.02

1.0

1.5

—

(37021550) Renin [Units/volume] in Plasma --upright

162

430

2.07

14.96

1.2

1.4

79.0

85.9

mu/l

0.11

116

324

(3015183) Erythrocyte sedimentation rate

416

1469

1.56

14.94

1.3

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.63

14.94

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

197

563

1.93

14.89

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

485

1776

1.50

14.79

1.3

1.4

12.5

11.6

umol/l

2.01

460

1679

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1200

5121

1.29

14.71

1.1

1.0

1.1

u/ml

0.17

498

2090

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

153

400

2.10

14.70

1.4

26.8

22.9

0.77

134

328

(3041918) Cholesterol [Moles/volume] in Pleural fluid

134

332

2.22

14.66

1.2

1.7

1.6

mmol/l

0.30

193

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

260

817

1.75

14.62

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

157

2.84

14.48

1.1

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

5033

24590

1.14

14.46

2.2

2.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

196

565

1.91

14.46

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

202

591

1.88

14.27

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

126

309

2.24

14.13

3.9

5.4

68.5

44.0

u/l

0.65

127

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

163

444

2.02

14.10

1.3

1.2

82.8

39.9

mg/l

0.45

117

328

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

153

408

2.06

14.00

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

215

2.51

13.95

1.3

1.2

724.0

59.7

u/l

0.78

157

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

120

290

2.28

13.92

1.4

1.5

367718.2

129803.0

nmol/l

0.74

245

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

238

740

1.77

13.90

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

285

933

1.68

13.89

3.4

5.4

2083.6

3149.5

mg/l

0.34

207

638

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

199

585

1.87

13.88

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

184

528

1.92

13.79

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

193

563

1.89

13.78

1.1

6.5

6.9

mg/g

0.33

183

534

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

4981

30610

0.89

13.75

1.7

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

193

564

1.88

13.71

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

254

810

1.73

13.62

2.8

3.0

27.7

29.0

umol/l

0.73

192

622

(3036048) Francisella tularensis Ab [Titer] in Serum

189

550

1.89

13.60

1.2

524.4

506.7

titre

—

(3042733) HLA Ab [Presence] in Serum

231

717

1.77

13.58

5.2

5.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

4015

19411

1.15

13.51

2.0

1.9

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

977

4109

1.31

13.39

1.1

5.6

4.8

u/ml

0.40

412

1685

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

194

573

1.86

13.36

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

133

343

2.13

13.27

1.0

76.9

81.5

ug/l

0.59

110

283

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1136

4896

1.28

12.96

1.5

1.4

0.4

nmol/l

0.89

887

3926

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

211

647

1.79

12.94

1.5

1.6

9.3

8.6

ug/l

1.37

211

647

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

112

273

2.26

12.79

1.4

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

993

4220

1.30

12.64

1.1

2.7

2.9

u/ml

0.29

416

2260

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

123

315

2.15

12.52

1.1

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

114

283

2.22

12.50

1.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

170

493

1.90

12.41

1.1

1.3

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

195

2.48

12.34

1.3

1.1

52.1

44.1

mg/l

0.67

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1284

5654

1.25

12.28

1.7

1.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

260

861

1.66

12.22

2.5

2.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

110

272

2.22

12.18

2.4

1.9

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

883

0.41

12.12

1.2

—

(40757373) Influenza virus identified in Isolate

141

387

2.00

12.04

2.0

1.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

200

618

1.78

12.00

1.4

62.7

0.01

165

502

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

919

3898

1.30

11.90

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

145

404

1.97

11.89

2.2

2.3

7.3

7.4

mmol/l

0.02

249

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

132

357

2.03

11.74

2.5

60.6

43.9

mg/l

0.24

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

195

2.43

11.54

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

138

382

1.99

11.54

1.2

1.4

727.5

109.1

ng/l

0.49

237

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

488

1886

1.42

11.45

1.8

1.9

2.1

2.3

u/field

0.25

256

776

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

173

519

1.83

11.44

9.6

8.7

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

348

1260

1.52

11.33

1.1

5.7

10.9

u/ml

2.12

224

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

840

3555

1.30

11.10

1.1

1.0

0.4

0.5

u/ml

0.24

200

710

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

129

354

2.00

11.06

4.7

5.8

—

(3016750) Collection duration of Urine

363

1334

1.50

11.04

2.1

2.2

498.0

497.1

min

0.05

247

1031

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

199

2.35

10.70

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1013

4413

1.27

10.69

1.1

4.4

4.6

u/ml

0.09

420

1689

(3033799) Differential panel - Peritoneal fluid

162

488

1.83

10.62

1.9

1.8

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

173

532

1.79

10.62

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

110

289

2.09

10.59

1.4

1.3

54.9

169.8

titre

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1344

6062

1.22

10.38

1.5

1.4

119.3

103.4

pmol/l

0.53

1296

5926

(3024869) Neuronal Ab [Presence] in Serum

132

375

1.94

10.32

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

412

1578

1.44

10.22

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

233

2.19

10.08

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

192

2.32

9.96

1.1

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2213

10480

1.17

9.94

1.3

208.5

229.5

miu/ml

1.83

919

5155

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

4.26

9.91

1.4

133.2

100.3

ug/l

0.38

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

402

1543

1.43

9.88

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1042

4601

1.25

9.84

1.6

1.5

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

512

2061

1.37

9.58

4.2

3.4

36.0

40.1

u/ml

0.32

506

2040

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

122

347

1.93

9.55

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

221

755

1.61

9.34

1.3

1.2

19.3

18.7

0.04

132

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

494

1986

1.37

9.33

1.7

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

231

2.14

9.25

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

206

2.22

9.24

1.4

65.4

70.9

0.71

171

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

114

321

1.95

9.20

4.9

5.0

49.2

40.2

ug/min

0.69

247

(3038071) Oxygen [Partial pressure] in Mixed venous blood

147

451

1.79

9.17

9.9

8.6

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

147

451

1.79

9.17

1.1

0.7

3.9

umol/24h

0.51

231

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

117

333

1.93

9.16

1.2

1.1

—

(44806071)

118

337

1.93

9.15

1.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

185

607

1.68

9.15

1.2

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

173

2.32

9.02

1.0

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

118

339

1.91

9.01

1.2

0.3

nmol/l

0.27

234

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.07

8.91

1.2

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

185

2.26

8.86

3.2

3.0

1.1

1.3

mg/l

0.37

123

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.32

8.84

1.2

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

3.25

8.81

1.1

1.0

0.2

g/l

0.39

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

208

2.17

8.70

2.2

2.1

—

(3024471) HLA-A [Type]

213

735

1.59

8.69

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

157

500

1.73

8.67

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

157

500

1.73

8.67

1.2

1.1

—

(3024932) HLA-DR beta [Type]

208

717

1.60

8.53

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

156

499

1.72

8.49

1.2

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

788

5413

0.80

8.43

1.4

1.3

3.8

3.6

ug/l

0.14

714

4940

(40768795) Lymph node Pathology biopsy report

547

2273

1.33

8.38

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

201

2.16

8.34

2.8

2.4

0.8

1.1

mmol/l

0.55

142

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

234

2.07

8.33

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

410

1634

1.38

8.24

1.3

1.2

4.5

5.6

umol/l

6.80

373

1525

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

103

2.67

8.21

1.1

u/field

0.17

(3010370) Gastrin [Moles/volume] in Serum or Plasma

116

343

1.86

8.18

1.8

51.0

46.1

pmol/l

0.20

284

(3011048) Pyruvate [Moles/volume] in Blood

120

2.52

8.11

1.3

1.4

83.1

75.5

umol/l

0.75

112

(3001893) Eosinophils/100 leukocytes in Pleural fluid

165

544

1.67

8.08

1.4

2.7

2.6

0.08

137

453

(3000919) Neutrophils/100 leukocytes in Pleural fluid

152

490

1.71

8.08

1.4

26.1

20.9

1.34

138

444

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

137

2.41

8.07

2.7

2.3

2.4

mg/l

0.13

114

(3013466) aPTT in Blood by Coagulation assay

141

2.38

8.00

1.1

35.8

37.3

1.05

118

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

549

2302

1.31

7.93

1.4

1.3

123.1

112.2

pmol/l

0.07

203

666

(44786800) Granulocytes/100 leukocytes in Body fluid

199

2.13

7.85

1.3

24.2

27.2

0.30

147

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

180

612

1.62

7.85

1.1

56.3

63.2

u/ml

0.64

175

600

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

171

575

1.64

7.79

1.9

47.6

36.9

u/l

0.27

161

516

(3014148) Varicella zoster virus Ab [Titer] in Serum

854

3793

1.24

7.77

1.2

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

120

2.47

7.70

1.1

46.7

54.1

u/l

0.43

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

139

444

1.72

7.66

1.1

—

(3051339) Copper [Moles/volume] in Blood

104

2.59

7.64

1.1

1.2

16.6

16.8

umol/l

0.08

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

4.48

7.48

1.3

1.1

376.7

392.3

au/ml

—

(3004775) Volume in Urine collected for unspecified duration

454

1869

1.34

7.48

2.1

2.3

744.2

652.3

3.36

294

1300

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

132

2.37

7.48

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

327

1281

1.40

7.33

1.1

1537.7

1495.0

miu/ml

0.27

327

1281

(4133840)

214

773

1.52

7.25

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

443

1827

1.33

7.23

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

176

610

1.59

7.15

1.9

1.8

6174.9

3046.9

e6/l

0.29

119

411

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

103

310

1.83

6.95

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

109

334

1.79

6.95

1.1

2.5

8.5

pmol/l

0.60

(3042010) Triglyceride [Moles/volume] in Pleural fluid

275

1.88

6.92

1.3

1.2

0.6

1.5

mmol/l

1.46

167

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

156

530

1.62

6.89

1.8

1.7

18029.7

9069.7

e6/l

0.65

267

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

260

989

1.45

6.88

3.3

3.4

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

292

1135

1.42

6.87

1.4

74.1

72.9

0.84

274

1082

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

245

1.93

6.84

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

101

304

1.83

6.83

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

129

2.30

6.67

1.1

—

(4212803)

161

2.15

6.67

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

158

2.16

6.61

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

241

1.92

6.57

1.1

—

(3035082) Kappa light chains [Mass/volume] in Urine

3.49

6.56

1.1

0.0

0.1

g/l

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

230

863

1.47

6.55

1.2

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

298

2243

0.73

6.50

1.3

1.4

30.2

32.0

nmol/l

0.54

254

2084

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

284

1112

1.41

6.45

1.4

578.4

694.9

mu/l

0.39

266

1059

(3014891) Appearance of Pleural fluid

235

1.92

6.44

1.5

1.6

—

(3020618) Glucose [Moles/volume] in Synovial fluid

3.11

6.44

1.0

1.1

6.2

5.0

mmol/l

0.57

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

132

2.25

6.36

1.0

1.1

19.5

20.3

u/ml

0.03

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

132

2.25

6.36

1.0

1.1

38.3

19.0

u/ml

0.89

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.30

6.32

1.7

1.4

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.83

6.28

19.0

16.4

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

158

2.12

6.28

1.1

1.0

23.9

12.3

iu/ml

0.39

(3020393) Adenovirus Ag [Presence] in Stool

192

2.00

6.22

1.1

1.0

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

2.44

6.19

1.3

1.8

0.8

0.7

umol/l

0.28

(36303858) Crystals [Presence] in Urine

4.50

6.17

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

260

1.84

6.06

2.0

1.9

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

272

1.82

6.06

3.0

2.8

—

(3020650) Glucose [Presence] in Urine

201

747

1.48

6.05

1.5

1.3

—

(3006969) Lambda light chains [Mass/volume] in Urine

3.47

6.04

1.0

1.1

0.0

0.1

g/l

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

272

1073

1.39

5.96

1.1

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

492

0.46

5.96

5.1

5.7

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

133

2.19

5.90

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.50

5.90

1.3

1.4

502.3

533.9

nmol/l

0.12

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

2.43

5.87

1.2

1.3

1.8

1.5

mg/l

1.06

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

804

3663

1.21

5.85

4.2

2.9

42.6

30.0

u/ml

1.10

775

3522

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

102

2.37

5.84

11.0

8.9

178.5

410.7

e6/l

0.64

(40765096) Chromosome analysis panel by Banding

163

584

1.53

5.84

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

245

1.84

5.74

2.4

2.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

183

1.98

5.73

1.1

22.8

19.8

u/l

0.43

117

(3011897) Casein IgE Ab [Units/volume] in Serum

123

415

1.63

5.67

1.1

1.2

0.2

5.9

u/ml

1.22

(3000330) Specific gravity of Urine by Test strip

2520

12514

1.11

5.60

3.7

3.1

—

(3018133) Calcium [Moles/volume] in Urine

100

321

1.71

5.55

1.3

1.6

2.4

2.8

mmol/l

0.94

289

(3001686) Cold agglutinin [Titer] in Serum or Plasma

120

405

1.63

5.54

1.3

27.9

198.5

titre

1.72

(3024316) Viscosity of Plasma

105

2.30

5.51

1.4

1.8

1.4

1.7

mpas

2.83

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2309

11423

1.11

5.51

1.7

1.6

4.1

3.1

mg/l

4.22

1811

7581

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

213

1.88

5.51

6.5

7.6

0.3

0.5

umol/l

0.50

194

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

141

2.11

5.50

1.3

19.3

17.3

pmol/l

0.20

119

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

259

1029

1.38

5.48

1.1

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

134

2.13

5.47

2.3

2.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

3379

17056

1.09

5.40

1.7

1.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

121

413

1.61

5.36

1.1

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

1029

6587

0.86

5.35

5.1

3.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

142

1172

0.66

5.33

2.7

3.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

673

3043

1.22

5.33

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

113

380

1.63

5.31

1.7

1.3

80.2

26.2

g/l

0.48

300

(3025315) Body weight

166

1.99

5.28

4.9

4.0

—

(3050794) Legionella sp Ab [Presence] in Serum

201

1.89

5.25

1.2

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

126

437

1.59

5.24

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

119

407

1.61

5.24

1.1

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.62

5.22

1.2

1.1

1.9

1.1

u/field

0.41

(3027035) Albumin [Mass/time] in 24 hour Urine

202

1.88

5.18

1.3

570.6

268.5

mg/24h

—

(3036005) Urine sediment comments by Light microscopy Narrative

4.81

5.15

1.0

1.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.30

5.14

3.1

3.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

127

444

1.57

5.12

1.4

1.3

13.1

13.6

g/l

0.20

337

(3009871) Measles virus Ab [Titer] in Serum

222

872

1.40

5.06

1.8

1.6

—

(3011544) Albumin [Mass/volume] in Pleural fluid

165

1.97

5.06

1.2

1.1

15.7

16.8

g/l

0.44

153

(3013727) Leukocytes other/100 leukocytes in Blood

182

691

1.45

5.00

3.1

3.6

55.5

50.9

2.01

176

660

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

265

1.74

5.00

2.8

3.1

39.8

42.5

umol/l

0.48

227

(3019174) dRVVT (LA screen)

245

1.75

4.73

1.1

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.31

4.72

10.2

8.6

—

(3035933) Granulocytes/100 leukocytes in Blood

181

695

1.43

4.72

1.5

2.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

139

2.02

4.71

1.3

1.4

317.3

301.2

umol/24h

0.21

139

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

170

1.91

4.68

3.0

45.4

79.0

pmol/l

0.32

(3020123) Porphyrins [Interpretation] in Serum or Plasma

136

2.02

4.65

1.3

1.0

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

191

1.84

4.59

1.4

15.9

14.1

pmol/l

0.08

156

(3025130) Human papilloma virus identified in Specimen

946

4475

1.16

4.57

1.8

1.7

—

(3022689) Creatine [Moles/volume] in Urine

180

696

1.42

4.54

1.5

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

188

1.84

4.52

1.4

2.1

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.21

4.52

1.0

0.2

0.1

u/ml

0.76

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

101

2.18

4.48

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

150

1.94

4.44

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

102

2.16

4.39

1.2

1.5

162.5

185.9

ug/g

0.48

(3021162) Amylase [Enzymatic activity/volume] in Specimen

306

1.63

4.36

3.0

2.7

2111.9

1492.0

u/l

0.25

280

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

105

366

1.58

4.35

7.0

7.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

130

477

1.50

4.30

2.2

2.7

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

107

2.11

4.26

1.8

1.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

188

1.81

4.26

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

107

377

1.56

4.25

1.1

0.0

0.4

u/ml

1.89

229

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

5.04

4.24

1.9

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

126

2.01

4.23

1.1

1.0

—

(3012898) Urea [Moles/volume] in Urine

234

1.71

4.18

1.4

1.7

155.1

173.8

mmol/l

0.68

212

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

710

3308

1.18

4.18

2.3

2.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

259

1.68

4.18

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

259

1.68

4.18

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

208

841

1.36

4.09

1.4

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

552

2520

1.21

4.08

4.4

4.8

122.9

90.3

u/ml

0.38

144

821

(3017509) Phencyclidine [Presence] in Urine

101

357

1.56

3.99

1.7

1.8

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

331

1.58

3.98

1.1

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.69

3.98

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

319

1.59

3.94

1.1

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

107

2.05

3.94

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

256

1.65

3.89

1.2

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

3.66

3.84

1.6

1.4

0.4

0.6

u/field

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

143

1.88

3.82

2.1

63.2

62.2

0.06

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.69

3.81

8.7

7.9

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

309

1.58

3.81

1.0

—

(3044007) Cell count panel - Peritoneal fluid

133

504

1.45

3.81

1.9

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.50

3.79

2.3

3.7

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

128

1.93

3.78

5.9

3.5

—

(3027874) Urate [Moles/volume] in Urine

2.31

3.76

1.1

1.0

1.4

10.0

mmol/l

0.54

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.15

3.74

1.0

0.1

0.0

u/ml

0.48

(3011335) Digoxin [Mass/volume] in Serum or Plasma

152

1.84

3.74

2.0

2.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

341

1.55

3.74

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

129

1.92

3.70

1.1

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

2.63

3.68

1.6

1.3

2.1

2.3

mmol/24h

0.29

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

2.68

3.64

6.7

7.7

35.7

49.1

1.15

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

126

1.92

3.64

1.6

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

166

1.79

3.61

1.1

10.1

9.3

mg/l

0.22

149

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.53

3.58

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

119

1.94

3.58

1.1

1.0

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

2.41

3.55

5.6

6.5

1.6

1.0

mg/l

0.52

(3032743) Legionella sp IgG Ab [Presence] in Serum

159

1.80

3.54

1.2

1.1

—

(40768793) Breast Pathology biopsy report

1182

5790

1.12

3.52

1.3

—

(3007456) Orange IgE Ab [Units/volume] in Serum

2.34

3.49

1.1

1.0

0.1

0.2

u/ml

0.42

(3045683) HLA typing for celiac disease panel - Blood or Tissue

392

1761

1.22

3.48

1.0

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.16

3.47

1.1

1.3

1.0

1.2

u/field

0.65

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

313

1.55

3.44

2.2

2.7

70.0

66.5

pmol/l

0.08

267

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.28

3.44

1.1

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

110

1.95

3.38

1.1

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.62

3.34

1.1

1.5

87.3

44.7

e6/l

0.34

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.33

3.33

1.1

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.27

3.27

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.15

3.25

1.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

102

380

1.48

3.24

1.7

1.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

266

1.57

3.21

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

158

1162

0.75

3.20

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

215

1.64

3.18

1.0

2.6

4.9

u/ml

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

165

1.73

3.18

1.1

1.0

9.4

10.6

u/l

0.20

165

(3004446) Plasmodium sp identified in Blood by Light microscopy

315

1.52

3.17

2.3

2.7

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.75

3.10

1.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

230

1.60

3.08

1.1

1.7

3.3

umol/24h

0.48

230

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.20

3.07

1.2

1.1

—

mmol/l

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

167

1.71

3.06

1.2

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

115

1.86

3.02

4.9

5.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

132

1.79

2.95

1.3

1.4

—

(4281824)

519

2436

1.17

2.93

1.1

—

(3017400) Magnesium [Moles/volume] in Urine

2.75

2.93

1.1

1.2

2.4

2.2

mmol/l

0.14

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.98

2.93

1.2

1.1

0.1

g/l

0.05

(3042951) Complement C1q Ab [Units/volume] in Serum

117

1.83

2.88

1.3

15.0

18.8

u/ml

—

(3022229) Phosphate [Moles/volume] in Urine

2.09

2.85

1.0

1.3

15.6

18.7

mmol/l

0.37

(3030940) RBC casts [#/area] in Urine by Computer assisted method

6.41

2.83

1.0

1.2

—

(36304079) Mucus [Presence] in Urine sediment

6.41

2.83

1.0

1.2

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

6.41

2.83

1.0

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

355

1618

1.21

2.82

6.1

6.7

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.10

2.79

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

303

1363

1.22

2.75

1.6

1.9

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

174

1.64

2.68

1.0

0.3

2.2

u/ml

1.21

132

(3033942) Copper [Moles/time] in 24 hour Urine

109

1.82

2.61

1.1

1.2

0.2

0.9

umol/24h

1.29

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

167

1.65

2.61

1.0

0.2

0.6

u/ml

1.21

153

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

2.14

2.60

1.0

0.2

0.7

u/ml

1.09

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.46

2.57

1.1

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2267

11640

1.07

2.55

2.0

1.9

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

147

1.68

2.55

1.1

15.5

15.9

nmol/l

0.05

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

183

1.59

2.45

1.0

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

110

445

1.36

2.33

1.1

3.4

1.5

u/ml

0.35

303

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.96

2.30

1.0

1.2

1793.8

2958.9

ng/l

0.76

(40762887) Creatinine [Moles/volume] in Blood

2.25

2.29

1.3

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.25

2.29

2.3

2.2

1.7

2.5

mu/l

0.54

(3015076) Soybean IgE Ab [Units/volume] in Serum

361

1685

1.18

2.28

1.0

0.6

0.7

u/ml

0.14

235

(3034614) HLA Ag [Interpretation]

2.05

2.26

1.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.01

2.25

1.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.75

2.23

1.0

1.2

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

154

1.61

2.19

1.6

0.6

0.02

119

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

275

1.44

2.14

1.3

1.4

12.4

12.3

0.01

129

(3012494) Peanut IgE Ab [Units/volume] in Serum

182

800

1.25

2.13

1.1

4.6

2.0

u/ml

0.36

117

413

(3021367) Citalopram [Moles/volume] in Serum or Plasma

2.07

2.13

1.5

160.8

128.8

nmol/l

0.33

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

312

0.62

2.12

1.0

—

(3001729) Color of Synovial fluid

182

1.54

2.10

1.5

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

165

1.57

2.08

1.3

1.2

1.7

ml/s/173m2

0.32

101

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

205

917

1.23

2.07

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

127

895

0.78

2.02

2.7

3.3

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

3.85

2.02

1.0

1.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

3.85

2.02

1.0

1.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

119

1.66

2.02

2.3

2.0

12.5

16.7

0.42

(3039443) Prostate specific Ag panel - Serum or Plasma

974

4887

1.10

2.02

1.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

127

894

0.78

2.00

5.3

6.6

—

(40759632) Porphyrins [Mass/mass] in Stool

2.54

1.95

1.1

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.54

1.95

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.54

1.95

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.54

1.95

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.54

1.95

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.54

1.95

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.54

1.95

2.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

170

1152

0.81

1.93

2.8

2.4

121.6

155.5

nmol/l

6.29

151

1004

(46236302) HLA-C [Type] by High resolution typing

1.86

1.93

1.0

—

(40760409) HLA-A [Type] by High resolution

1.86

1.93

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

1.86

1.93

1.5

—

(40763590) HLA-DQ beta [Type]

1.86

1.93

1.0

—

(40760410) HLA-B [Type] by High resolution

1.86

1.93

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

151

1.57

1.92

1.1

—

(3018291) Platelet Ab [Presence] in Serum

2.23

1.90

1.1

—

(3009992) Blasts/100 cells in Bone marrow

3.50

1.87

2.1

1.9

14.3

18.1

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

3.50

1.87

1.0

1.1

18.7

15.8

umol/l

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

265

1.41

1.86

1.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

103

430

1.32

1.85

1.8

1.5

2.8

2.0

ug/l

0.81

256

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

2.26

1.84

1.4

1.2

—

(3045177) Copper [Moles/volume] in Urine

2.26

1.84

1.0

1.1

0.3

0.6

umol/l

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

2.26

1.84

1.1

1.0

0.3

0.2

u/ml

—

(3011325) HIV 1+2 Ab [Presence] in Serum

140

1.57

1.83

1.1

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

412

1.32

1.82

2.6

2.5

—

(3013862) HLA-DP [Type]

1.81

1.80

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

119

1.62

1.80

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

391

1880

1.14

1.76

1.1

1.0

0.7

2.0

u/ml

1.09

116

469

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

2.93

1.75

1.0

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

250

1.41

1.75

1.0

0.1

0.9

u/ml

0.93

177

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

142

1.55

1.73

1.0

1.1

2.6

2.9

u/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

9498

50929

1.03

1.73

1.5

—

(3003157) Bacteria [#/volume] in Mother's milk

0.39

1.72

2.0

7.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

178

1.48

1.72

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.23

1.67

8.5

3.2

—

(3042301) Urate [Moles/volume] in Synovial fluid

2.14

1.64

1.0

456.2

326.9

umol/l

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.69

1.64

1.0

0.1

u/ml

0.02

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

158

1.50

1.62

1.1

1.0

14.3

17.2

u/ml

0.24

126

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

114

1.59

1.62

1.1

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

2.00

1.60

5.9

5.5

5.8

7.0

mg/l

0.14

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

354

1.32

1.60

1.3

55.7

51.5

0.31

167

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

111

1.58

1.55

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

147

1.50

1.52

1.6

1.3

23.4

21.9

mmol/l

0.98

(3021374) Sirolimus [Mass/volume] in Blood

2.60

1.52

10.8

9.7

7.6

6.8

ug/l

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

162

1.46

1.6

1.5

9.2

14.0

0.95

113

(3001556) Androgen free Index in Serum or Plasma

369

1.30

1.46

1.3

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

264

1255

1.16

1.46

2.1

1.9

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

288

1.34

1.45

2.2

0.5

0.6

u/field

0.21

288

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.96

1.45

1.0

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

204

1.40

1.44

1.0

0.1

1.2

u/ml

0.82

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.24

1.44

2.0

2.1

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

186

1.42

1.5

36.5

36.6

0.00

125

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

241

1531

0.86

1.41

1.1

1.3

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.13

1.41

1.2

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

151

1.46

1.37

1.2

1.1

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.59

1.35

1.0

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.25

1.35

1.0

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

307

1.31

1.33

1.0

0.0

0.2

u/ml

2.30

184

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

189

1.40

1.32

1.0

0.2

0.9

u/ml

0.65

117

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

103

1.55

1.31

1.1

1.0

—

(3000285) Sodium [Moles/volume] in Blood

289

1.31

1.30

1.2

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.83

1.30

1.3

1.1

2.1

2.7

0.63

(3042628) Porphyrins [Moles/volume] in Urine

3.05

1.29

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

3.05

1.29

4.0

2.3

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

135

1.47

1.28

1.5

1.3

2.3

1.6

0.25

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

247

1.33

1.28

1.0

0.2

1.8

u/ml

0.98

180

(3015350) Toxocara sp Ab [Presence] in Serum

2.20

1.27

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.08

1.24

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

379

1870

1.11

1.23

1.0

1.4

2.4

u/ml

0.68

405

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

345

2113

0.90

1.19

1.9

1.8

—

(40758292) HTLV I+II Ab panel - Serum

396

1.25

1.19

1.3

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

106

1.50

1.18

1.8

1.5

0.0

0.2

u/l

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

2.56

1.17

1.1

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.79

1.15

1.0

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

560

0.80

1.13

3.1

2.5

88.8

94.7

ng/l

0.12

264

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

2.40

1.13

1.0

1.1

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

112

1.47

1.12

1.1

8.1

8.7

0.61

105

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

112

1.47

1.12

1.1

36.5

35.8

0.31

106

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

112

1.47

1.12

1.1

20.3

21.4

0.73

105

(3038515) Glucose [Moles/volume] in Venous blood

862

5055

0.94

1.11

3.8

2.9

7.4

7.5

mmol/l

0.67

840

4975

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

143

0.61

1.10

1.0

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.04

1.08

1.3

3.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

160

1.37

1.06

1.2

1.1

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

2.14

1.03

1.1

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

171

1.35

1.01

4.6

4.3

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.90

1.00

1.1

1.0

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

259

1.27

0.97

1.0

0.1

0.6

u/ml

1.66

147

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

107

1.44

0.96

1.5

1.2

596.2

1033.8

u/l

0.29

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.52

0.93

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.83

0.92

1.0

1.1

1150.9

2192.7

titre

1.56

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

2.20

0.92

1.2

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

2.20

0.92

1.0

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.65

0.91

1.1

1.0

0.8

0.4

u/ml

—

(3007700) Barley IgE Ab [Units/volume] in Serum

132

1.37

0.90

1.1

1.0

0.2

10.2

u/ml

0.53

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

217

1335

0.89

1.2

1.3

—

(40768800) Prostate Pathology biopsy report

874

4545

1.06

0.86

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

321

1.22

0.81

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

164

1.31

0.80

1.4

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.60

0.78

1.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.50

0.78

1.2

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.47

0.76

1.0

122.1

265.3

pmol/l

1.66

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.56

0.76

1.3

1.2

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.11

0.74

1.0

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

128

1.33

0.73

1.0

—

(3035285) Chloride [Moles/volume] in Venous blood

555

2867

1.06

0.72

2.5

2.1

105.5

105.8

mmol/l

1.00

550

2843

(3041354) Potassium [Moles/volume] in Venous blood

555

2867

1.06

0.72

2.5

2.1

4.0

mmol/l

0.00

550

2843

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.75

0.71

1.6

1.8

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

1.96

0.70

1.0

2.9

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

1.96

0.70

1.0

1.1

24.0

33.6

umol/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1881

10663

0.97

0.68

1.5

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1967

10481

1.03

0.68

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

833

4363

1.05

0.68

1.4

7.3

7.0

mmol/l

2.07

643

3052

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

159

1.28

0.68

1.1

6.8

u/ml

0.01

112

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

363

0.83

0.64

5.5

7.9

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

280

1.20

0.64

1.0

0.9

0.5

u/ml

0.22

148

(3020356) Listeria sp identified in Specimen by Organism specific culture

248

0.80

0.63

1.2

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

161

1.26

0.63

1.4

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

1.63

0.62

1.1

1.3

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

180

0.76

0.62

1.1

0.3

1.4

u/ml

1.39

120

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

227

1143

1.09

0.61

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

167

1.25

0.60

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.62

0.59

1.0

151.4

142.7

mmol/24h

—

(37019676) Renin [Units/volume] in Plasma --supine

1.53

0.59

1.0

1.1

166.8

37.2

mu/l

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.36

0.58

1.0

0.3

u/ml

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

1.52

0.58

1.0

—

(3022475) Manganese [Moles/volume] in Blood

158

1.25

0.58

1.1

1.3

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

188

1.23

0.57

1.1

1.2

16.0

24.1

0.43

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.49

0.57

1.1

78.4

111.1

nmol/24h

1.25

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.55

0.56

1.1

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.50

0.55

1.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.50

0.55

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1025

5841

0.96

0.55

4.5

2.9

24.9

26.7

mg/l

0.82

593

3733

(3004959) Base excess in Arterial cord blood by calculation

0.61

0.54

1.3

1.1

—

-0.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

382

1976

1.06

0.53

1.3

1.5

g/l

0.48

114

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

168

0.78

0.51

1.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

188

952

1.09

0.49

1.1

1.0

9.1

11.5

u/ml

0.24

133

(4038314)

264

1.17

0.48

1.2

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.34

0.47

1.0

0.0

0.1

u/ml

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.48

0.47

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.31

0.46

1.1

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

129

0.77

0.46

1.0

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

276

1.15

0.45

1.0

0.2

u/ml

0.03

152

(3007542) Rye IgE Ab [Units/volume] in Serum

154

1.21

0.45

1.1

1.0

0.2

11.8

u/ml

0.52

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.40

0.44

1.2

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.32

0.44

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.35

0.43

2.3

1.2

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.42

0.0

1.7

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.33

0.42

1.1

1.0

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

1.53

0.41

1.0

1.3

259.6

312.9

nmol/l

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

102

0.75

0.41

1.7

2.0

—

(3006598) pH of Arterial cord blood

0.67

0.41

1.3

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

104

518

1.10

0.41

1.1

1.2

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.75

0.39

1.0

—

(1761868) Lipid panel - Serum or Plasma

19545

107967

0.99

0.39

2.7

2.6

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.30

0.39

1.0

1.1

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

107

1.23

0.38

1.0

0.0

0.1

u/ml

1.51

(3033705) Calcium.ionized [Moles/volume] in Venous blood

537

2838

1.04

0.38

2.6

2.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

411

0.90

0.36

12.1

6.5

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.37

0.35

1.1

1.2

—

(3022670) pH of Venous cord blood

0.66

0.34

1.0

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

104

1.22

0.33

2.5

3.4

0.0

estimate

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.25

0.33

1.2

1.1

249.9

227.0

nmol/l

0.18

(44806420)

124

632

1.08

0.32

2.4

—

(3041184) Isoniazid [Presence] in Urine

1.37

0.32

2.0

2.9

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.37

0.32

1.3

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

290

1523

1.05

0.30

1.0

390.4

331.8

ng/l

0.19

206

1076

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

266

1530

0.96

0.29

1.3

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

292

1536

1.04

0.29

1.0

41.6

43.3

ng/l

0.09

202

1067

(40758358) Immune stain study

106

1.19

0.28

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.20

0.28

1.1

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

889

4773

1.02

0.27

2.0

2.1

7.0

6.0

umol/l

0.58

628

3493

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

291

1534

1.04

0.27

1.0

822.4

711.8

ng/l

4.12

197

1046

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

490

1.08

0.26

1.4

5.2

6.1

nmol/l

1.01

469

(3040794) Aluminum [Moles/volume] in Urine

1.27

0.26

1.2

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.74

0.23

1.3

1.1

4.2

5.4

kpa

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.19

0.23

1.1

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

387

0.92

0.23

1.2

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

340

1930

0.97

0.22

1.0

—

(3025311) HLA-B [Type]

0.00

0.22

0.0

1.0

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.22

0.0

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.22

0.22

1.4

1.1

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.0

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.22

0.0

1.0

—

(3013762) Body weight Measured

121

0.86

0.20

1.2

1.1

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

1.16

0.19

1.0

0.0

1.0

u/ml

0.74

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.21

0.19

4.8

5.6

0.2

mmol/l

0.15

(3007919) Fasciola sp Ab [Titer] in Serum

1.25

0.18

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.17

0.18

1.0

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

202

1.09

0.16

1.2

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.75

0.16

1.0

—

(3008037) Lactate [Moles/volume] in Venous blood

951

5299

0.99

0.15

3.7

2.8

1.6

mmol/l

0.47

925

5205

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

322

1726

1.03

0.15

1.4

5.7

5.5

mmol/l

3.30

304

1635

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.10

0.15

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

152

0.90

0.15

1.0

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

108

1.12

0.14

1.0

0.1

0.4

u/ml

0.91

(3019897) Erythrocyte distribution width [Ratio] by Automated count

851

4616

1.01

0.13

3.1

2.3

13.3

13.1

5.29

841

4557

(3029612) Listeria sp Ab [Titer] in Serum

1.13

0.11

1.2

1.4

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.16

0.11

2.4

2.2

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.14

0.09

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

251

1.05

0.09

1.4

1.6

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

545

2960

1.01

0.09

1.3

1.4

12.3

11.8

mmol/l

0.45

180

502

(46235168) Fasting glucose [Moles/volume] in Blood

357

0.97

0.06

4.0

1.5

7.4

6.9

mmol/l

0.29

127

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

154

0.96

0.03

1.1

8.3

8.6

mmol/l

0.30

154

(3009677) Dengue virus Ab [Presence] in Serum

116

1.04

0.02

1.1

1.2

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

160

1.03

0.02

3.6

1.8

24.9

15.5

0.90

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

117

647

0.99

0.00

1.9

—

(3016031) Almond IgE Ab [Units/volume] in Serum

187

1.00

0.00

1.1

1.0

0.2

0.5

u/ml

0.92

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.03

0.00

1.0

—

(3003577) Lead [Moles/volume] in Blood

229

1.01

0.00

1.4

0.2

umol/l

0.17

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(1176058) AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(1175312) AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: RX_CODEINE – Codeine

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Codeine

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Codeine (RX_CODEINE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints